<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1332" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1332/" /><meta name="ncbi_pagename" content="Congenital Disorders of N-Linked Glycosylation and Multiple Pathway Overview - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Congenital Disorders of N-Linked Glycosylation and Multiple Pathway Overview - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Congenital Disorders of N-Linked Glycosylation and Multiple Pathway Overview" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2017/01/12" /><meta name="citation_author" content="Susan E Sparks" /><meta name="citation_author" content="Donna M Krasnewich" /><meta name="citation_pmid" content="20301507" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1332/" /><meta name="citation_keywords" content="Carbohydrate-Deficient Glycoprotein Syndromes" /><meta name="citation_keywords" content="CDG Syndromes" /><meta name="citation_keywords" content="CDG Syndromes" /><meta name="citation_keywords" content="Carbohydrate-Deficient Glycoprotein Syndromes" /><meta name="citation_keywords" content="PMM2-CDG (CDG-Ia)" /><meta name="citation_keywords" content="Alpha-1,2-mannosyltransferase ALG9" /><meta name="citation_keywords" content="Alpha-1,3/1,6-mannosyltransferase ALG2" /><meta name="citation_keywords" content="Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase" /><meta name="citation_keywords" content="Beta-1,4-galactosyltransferase 1" /><meta name="citation_keywords" content="Chitobiosyldiphosphodolichol beta-mannosyltransferase" /><meta name="citation_keywords" content="CMP-sialic acid transporter" /><meta name="citation_keywords" content="Conserved oligomeric Golgi complex subunit 1" /><meta name="citation_keywords" content="Conserved oligomeric Golgi complex subunit 2" /><meta name="citation_keywords" content="Conserved oligomeric Golgi complex subunit 4" /><meta name="citation_keywords" content="Conserved oligomeric Golgi complex subunit 5" /><meta name="citation_keywords" content="Conserved oligomeric Golgi complex subunit 6" /><meta name="citation_keywords" content="Conserved oligomeric Golgi complex subunit 7" /><meta name="citation_keywords" content="Conserved oligomeric Golgi complex subunit 8" /><meta name="citation_keywords" content="Dehydrodolichyl diphosphate synthase complex subunit DHDDS" /><meta name="citation_keywords" content="Dolichol kinase" /><meta name="citation_keywords" content="Dolichol phosphate-mannose biosynthesis regulatory protein" /><meta name="citation_keywords" content="Dolichol-phosphate mannosyltransferase subunit 1" /><meta name="citation_keywords" content="Dolichol-phosphate mannosyltransferase subunit 3" /><meta name="citation_keywords" content="Dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase" /><meta name="citation_keywords" content="Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit" /><meta name="citation_keywords" content="Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A" /><meta name="citation_keywords" content="Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B" /><meta name="citation_keywords" content="Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase" /><meta name="citation_keywords" content="Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase" /><meta name="citation_keywords" content="Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase" /><meta name="citation_keywords" content="GDP-fucose transporter 1" /><meta name="citation_keywords" content="GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase" /><meta name="citation_keywords" content="Magnesium transporter protein 1" /><meta name="citation_keywords" content="Mannose-1-phosphate guanyltransferase alpha" /><meta name="citation_keywords" content="Mannose-6-phosphate isomerase" /><meta name="citation_keywords" content="Mannose-P-dolichol utilization defect 1 protein" /><meta name="citation_keywords" content="Mannosyl-oligosaccharide glucosidase" /><meta name="citation_keywords" content="Phosphoacetylglucosamine mutase" /><meta name="citation_keywords" content="Phosphoglucomutase-1" /><meta name="citation_keywords" content="Phosphomannomutase 2" /><meta name="citation_keywords" content="Polyprenol reductase" /><meta name="citation_keywords" content="Probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase" /><meta name="citation_keywords" content="Protein RFT1 homolog" /><meta name="citation_keywords" content="Putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13" /><meta name="citation_keywords" content="Translocon-associated protein subunit delta" /><meta name="citation_keywords" content="Transmembrane protein 165" /><meta name="citation_keywords" content="Tumor suppressor candidate 3" /><meta name="citation_keywords" content="UDP-galactose translocator" /><meta name="citation_keywords" content="UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase" /><meta name="citation_keywords" content="ALG1" /><meta name="citation_keywords" content="ALG11" /><meta name="citation_keywords" content="ALG12" /><meta name="citation_keywords" content="ALG13" /><meta name="citation_keywords" content="ALG2" /><meta name="citation_keywords" content="ALG3" /><meta name="citation_keywords" content="ALG6" /><meta name="citation_keywords" content="ALG8" /><meta name="citation_keywords" content="ALG9" /><meta name="citation_keywords" content="B4GALT1" /><meta name="citation_keywords" content="COG1" /><meta name="citation_keywords" content="COG2" /><meta name="citation_keywords" content="COG4" /><meta name="citation_keywords" content="COG5" /><meta name="citation_keywords" content="COG6" /><meta name="citation_keywords" content="COG7" /><meta name="citation_keywords" content="COG8" /><meta name="citation_keywords" content="DDOST" /><meta name="citation_keywords" content="DHDDS" /><meta name="citation_keywords" content="DOLK" /><meta name="citation_keywords" content="DPAGT1" /><meta name="citation_keywords" content="DPM1" /><meta name="citation_keywords" content="DPM2" /><meta name="citation_keywords" content="DPM3" /><meta name="citation_keywords" content="GMPPA" /><meta name="citation_keywords" content="MAGT1" /><meta name="citation_keywords" content="MAN1B1" /><meta name="citation_keywords" content="MGAT2" /><meta name="citation_keywords" content="MOGS" /><meta name="citation_keywords" content="MPDU1" /><meta name="citation_keywords" content="MPI" /><meta name="citation_keywords" content="PGM1" /><meta name="citation_keywords" content="PGM3" /><meta name="citation_keywords" content="PMM2" /><meta name="citation_keywords" content="RFT1" /><meta name="citation_keywords" content="SLC35A1" /><meta name="citation_keywords" content="SLC35A2" /><meta name="citation_keywords" content="SLC35C1" /><meta name="citation_keywords" content="SRD5A3" /><meta name="citation_keywords" content="SSR4" /><meta name="citation_keywords" content="STT3A" /><meta name="citation_keywords" content="STT3B" /><meta name="citation_keywords" content="TMEM165" /><meta name="citation_keywords" content="TUSC3" /><meta name="citation_keywords" content="Congenital Disorders of N-Linked Glycosylation and Multiple Pathway Overview" /><meta name="citation_keywords" content="Overview" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Congenital Disorders of N-Linked Glycosylation and Multiple Pathway Overview" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Susan E Sparks" /><meta name="DC.Contributor" content="Donna M Krasnewich" /><meta name="DC.Date" content="2017/01/12" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1332/" /><meta name="description" content="Many human disorders of glycosylation pathways have now been identified; they include defects in synthetic pathways for N-linked oligosaccharides, O-linked oligosaccharides, shared substrates, glycophosphatidylinositol (GPI) anchors, and dolichols. This overview will focus on disorders of the N-linked glycan synthetic pathway and some disorders that overlap this metabolic network (multiple-pathway disorders)." /><meta name="og:title" content="Congenital Disorders of N-Linked Glycosylation and Multiple Pathway Overview" /><meta name="og:type" content="book" /><meta name="og:description" content="Many human disorders of glycosylation pathways have now been identified; they include defects in synthetic pathways for N-linked oligosaccharides, O-linked oligosaccharides, shared substrates, glycophosphatidylinositol (GPI) anchors, and dolichols. This overview will focus on disorders of the N-linked glycan synthetic pathway and some disorders that overlap this metabolic network (multiple-pathway disorders)." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1332/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/cdg/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1332/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8DCFAFE04076A10000000002BE00F2.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1332_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1332_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/cdh-ov/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/cda1/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1332_"><span class="title" itemprop="name">Congenital Disorders of N-Linked Glycosylation and Multiple Pathway Overview</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: Carbohydrate-Deficient Glycoprotein Syndromes, CDG Syndromes</div><p class="contrib-group"><span itemprop="author">Susan E Sparks</span>, MD, PhD and <span itemprop="author">Donna M Krasnewich</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK1332_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1332_ai__"><div class="contrib half_rhythm"><span itemprop="author">Susan E Sparks</span>, MD, PhD<div class="affiliation small">Sanofi Genzyme<br />Cambridge, Massachusetts<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.emyzneg@skraps.nasus" class="oemail">moc.emyzneg@skraps.nasus</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Donna M Krasnewich</span>, MD, PhD<div class="affiliation small">National Institutes of Health<br />Bethesda, Maryland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="vog.hin.liam@sarkd" class="oemail">vog.hin.liam@sarkd</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">August 15, 2005</span>; Last Update: <span itemprop="dateModified">January 12, 2017</span>.</p><p><em>Estimated reading time: 28 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="cdg.Summary" itemprop="description"><h2 id="_cdg_Summary_">Summary</h2><div><h4 class="inline">Purpose.</h4><p>Many human disorders of glycosylation pathways have now been identified; they include defects in synthetic pathways for N-linked oligosaccharides, O-linked oligosaccharides, shared substrates, glycophosphatidylinositol (GPI) anchors, and dolichols. This overview will focus on disorders of the N-linked glycan synthetic pathway and some disorders that overlap this metabolic network (multiple-pathway disorders).</p><p>The goals of this overview on <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> disorders of glycosylation are the following:</p></div><div><h4 class="inline">Goal 1.</h4><p>To describe the <a href="#cdg.Clinical_Characteristics_of_Congenit">clinical characteristics of congenital disorders of N-linked glycosylation</a></p></div><div><h4 class="inline">Goal 2.</h4><p>To review the <a href="#cdg.Causes_of_Congenital_Disorders_of_Gl">causes</a> of <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> disorders of N-linked glycosylation</p></div><div><h4 class="inline">Goal 3.</h4><p>To provide an <a href="#cdg.Evaluation_Strategy">evaluation strategy</a> to identify the genetic cause of <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> disorders of glycosylation in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></p></div><div><h4 class="inline">Goal 4.</h4><p>To inform (when possible) <a href="#cdg.Management">management</a></p></div><div><h4 class="inline">Goal 5.</h4><p>To inform <a href="#cdg.Genetic_Counseling">genetic counseling</a> of family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> disorders of N-linked glycosylation</p></div></div><div id="cdg.Clinical_Characteristics_of_Congenit"><h2 id="_cdg_Clinical_Characteristics_of_Congenit_">Clinical Characteristics of Congenital Disorders of Glycosylation</h2><p><b>Congenital disorders of N-linked glycosylation (CDG-N-linked)</b>
<b>pathway</b> &#x02013; for the purposes of this <i>GeneReview</i> &#x02013; refers to disorders of the N-linked glycan synthetic pathway and some disorders that overlap this metabolic network &#x02013; referred to here as multiple-pathway disorders.</p><p>CDG-N-linked are a group of disorders caused by the defective synthesis of N-linked oligosaccharides, sugars linked together in a specific pattern and attached to proteins and lipids (N-linked glycans link to the amide group of asparagine via an N-acetylglucosamine residue) [<a class="bk_pop" href="#cdg.REF.jaeken.2001.129">Jaeken &#x00026; Matthijs 2001</a>, <a class="bk_pop" href="#cdg.REF.gr_newald.2002.618">Gr&#x000fc;newald et al 2002</a>, <a class="bk_pop" href="#cdg.REF.freeze.2006.537">Freeze 2006</a>, <a class="bk_pop" href="#cdg.REF.gr_newald.2007.825">Gr&#x000fc;newald 2007</a>].</p><div id="cdg.Clinical_Manifestations"><h3>Clinical Manifestations</h3><p>Almost all types of <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> disorders of glycosylation (CDG) present in infancy. Because of the important biologic functions of the oligosaccharides in both glycoproteins and glycolipids, incorrect synthesis of these compounds results in broad multisystem clinical manifestations [<a class="bk_pop" href="#cdg.REF.varki.1993.97">Varki 1993</a>] that may include one or more of the following: failure to thrive, developmental delay, hepatopathy, hypotonia/neurologic abnormalities, hypoglycemia, protein-losing enteropathy, eye abnormalities, immunologic findings, skin abnormalities, and skeletal findings [<a class="bk_pop" href="#cdg.REF.rymen.2014.699">Rymen &#x00026; Jaeken 2014</a>]. It is becoming increasingly clear that the clinical spectrum can involve individual or multiple organ systems and may or may not affect neurodevelopment. CDG is increasingly being considered in the differential diagnosis for varied symptoms across multiple age groups and clinical specialties.</p><p>For many types of CDG, the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is not completely known because only a few <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have been reported.</p><p>Note: In 2009 the nomenclature for all types of CDG was changed to include the official <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> symbol (not italicized) followed by "-CDG." If the type has a known letter name, it is added in parentheses as shown for CDG type 1a; new nomenclature: PMM2-CDG (<i>CDG-Ia</i>) [<a class="bk_pop" href="#cdg.REF.jaeken.2009a.825">Jaeken et al 2009a</a>].</p><div id="cdg.CDG_NLinked"><h4>CDG N-Linked</h4><p><b>PMM2-CDG (<i>CDG-Ia</i>).</b> The typical clinical course of PMM2-CDG <i>(CDG-Ia)</i> has been divided into an infantile multisystem stage, late-infantile and childhood ataxia-intellectual disability stage, and adult stable disability stage; see <a href="/books/n/gene/cdg-1a/">PMM2-CDG (<i>CDG-Ia</i>)</a>. The phenotypic spectrum includes hydrops fetalis at the severe end [<a class="bk_pop" href="#cdg.REF.van_de_kamp.2007.277">van de Kamp et al 2007</a>] and a mild neurologic <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in adults with multisystemic involvement at the mild end [<a class="bk_pop" href="#cdg.REF.barone.2007.107">Barone et al 2007</a>, <a class="bk_pop" href="#cdg.REF.coman.2007.668">Coman et al 2007</a>].</p><p>The infantile multisystem stage, the most commonly seen stage, is characterized by failure to thrive, inverted nipples, abnormal subcutaneous fat distribution, and cerebellar hypoplasia, in combination with facial dysmorphism and developmental delay.</p><p>Neuroimaging may demonstrate the following:</p><ul><li class="half_rhythm"><div class="half_rhythm">An enlarged cisterna magna and superior cerebellar cistern in late infancy to early childhood</div><div class="half_rhythm">In 13 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, the extent of cerebellar involvement on brain imaging correlated with functional and cognitive assessments [<a class="bk_pop" href="#cdg.REF.serrano.2015.138">Serrano et al 2015</a>].</div></li><li class="half_rhythm"><div class="half_rhythm">Occasionally both infratentorial and supratentorial changes compatible with atrophy</div></li><li class="half_rhythm"><div class="half_rhythm">Dandy-Walker malformations and small white matter cysts</div></li><li class="half_rhythm"><div class="half_rhythm">Myelination that varies from normal to insufficient or delayed maturation</div></li><li class="half_rhythm"><div class="half_rhythm">Areas of ischemia or edema followed by focal necrosis in those who have had a recent stroke-like episode [<a class="bk_pop" href="#cdg.REF.ishikawa.2009.240">Ishikawa et al 2009</a>]</div></li></ul><p><b>MPI-CDG (<i>CDG-Ib</i>).</b> Cyclic vomiting, profound hypoglycemia, failure to thrive, liver fibrosis, and protein-losing enteropathy, occasionally associated with coagulation disturbances without neurologic involvement, are characteristic [<a class="bk_pop" href="#cdg.REF.de_koning.1998.38">de Koning et al 1998</a>, <a class="bk_pop" href="#cdg.REF.jaeken.1998.1535">Jaeken et al 1998</a>, <a class="bk_pop" href="#cdg.REF.niehues.1998.1414">Niehues et al 1998</a>, <a class="bk_pop" href="#cdg.REF.babovicvuksanovic.1999.775">Babovic-Vuksanovic et al 1999</a>, <a class="bk_pop" href="#cdg.REF.de_lonlay.1999.379">de Lonlay et al 1999</a>, <a class="bk_pop" href="#cdg.REF.adamowicz.2000.184">Adamowicz et al 2000</a>, <a class="bk_pop" href="#cdg.REF.de_lonlay.2009.841">de Lonlay &#x00026; Seta 2009</a>]. The clinical course is variable even within families.</p><p><b>ALG6-CDG (<i>CDG-Ic</i>)</b> is now considered to be a common type of CDG [<a class="bk_pop" href="#cdg.REF.jaeken.2015">Jaeken et al 2015</a>]. The characteristic clinical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of ALG6-CDG (<i>CDG-Ic</i>) (previously carbohydrate-deficient glycoprotein syndrome type V) includes hypotonia, developmental delay, ataxia and epilepsy [<a class="bk_pop" href="#cdg.REF.morava.2016.713">Morava et al 2016</a>].</p><ul><li class="half_rhythm"><div>The clinical presentation may be milder than in PMM2-CDG (<i>CDG-Ia</i>); stroke-like episodes and peripheral neuropathy have not been reported.</div></li><li class="half_rhythm"><div>Rare features have included brachydactyly, deep vein thrombosis, pseudotumor cerebri with normal brain MRI, pubertal abnormalities including hyperandrogenism with virilization, and retinal degeneration [<a class="bk_pop" href="#cdg.REF.sun.2005.22">Sun et al 2005</a>, <a class="bk_pop" href="#cdg.REF.kahook.2006.115">Kahook et al 2006</a>, <a class="bk_pop" href="#cdg.REF.miller.2011.101">Miller et al 2011</a>].</div></li></ul><p><b>ALG3-CDG (<i>CDG-Id</i>).</b> A total of 11 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have been described; features include severe neurologic involvement, microcephaly, seizures, <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> facial features, skeletal anomalies (arthrogryposis multiplex congenita, chondrodysplasia punctata), and eye anomalies (cataract, corneal opacities, iris coloboma) [<a class="bk_pop" href="#cdg.REF.lepais.2015.2748">Lepais et al 2015</a>].</p><p><b>DPM1-CDG (<i>CDG-Ie</i>).</b> Features may include severe developmental delay, microcephaly, seizures, ataxia, peripheral neuropathy, eye abnormalities (retinopathy, nystagmus, strabismus), and severe gastrointestinal involvement [<a class="bk_pop" href="#cdg.REF.dancourt.2006.835">Dancourt et al 2006</a>, <a class="bk_pop" href="#cdg.REF.bursle.2017.27">Bursle et al 2017</a>]. One infant presented with <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> muscular dystrophy similar to that seen in the dystroglycanopathies [<a class="bk_pop" href="#cdg.REF.yang.2013.345">Yang et al 2013</a>].</p><p><b>MPDU1-CDG (<i>CDG-If</i>).</b> Five individuals had severe developmental delay, generalized scaly, erythematous skin, and attacks of hypertonia [<a class="bk_pop" href="#cdg.REF.jaeken.2000.186">Jaeken et al 2000</a>, <a class="bk_pop" href="#cdg.REF.kranz.2001.1613">Kranz et al 2001</a>, <a class="bk_pop" href="#cdg.REF.schenk.2001.1687">Schenk et al 2001</a>].</p><p><b>ALG12-CDG (<i>CDG-Ig</i>).</b> Features may include generalized hypotonia, feeding difficulties, moderate to severe developmental delay, progressive microcephaly, seizures, <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> facial features, frequent upper respiratory tract infections, hypogonadism with or without hypospadias, impaired immunity with decreased immunoglobulin levels, cardiac anomalies, and decreased coagulation factors [<a class="bk_pop" href="#cdg.REF.chantret.2002.25815">Chantret et al 2002</a>, <a class="bk_pop" href="#cdg.REF.grubenmann.2002.2331">Grubenmann et al 2002</a>, <a class="bk_pop" href="#cdg.REF.thiel.2002.195">Thiel et al 2002</a>, <a class="bk_pop" href="#cdg.REF.zdebska.2003.224">Zdebska et al 2003</a>, <a class="bk_pop" href="#cdg.REF.di_rocco.2005.1162">Di Rocco et al 2005</a>, <a class="bk_pop" href="#cdg.REF.eklund.2005a.25">Eklund et al 2005a</a>, <a class="bk_pop" href="#cdg.REF.eklund.2005b.847">Eklund et al 2005b</a>, <a class="bk_pop" href="#cdg.REF.kranz.2007a.1371">Kranz et al 2007a</a>].</p><p><b>ALG8-CDG (<i>CDG-Ih</i>)</b> is characterized by severe multisystem involvement with seizures, distinctive facial features, protein-losing enteropathy, and hematopoietic issues (anemia, thrombocytopenia, decreased levels of factor XI, protein C, and antithrombin III) [<a class="bk_pop" href="#cdg.REF.chantret.2003.9962">Chantret et al 2003</a>, <a class="bk_pop" href="#cdg.REF.schollen.2004a.550">Schollen et al 2004a</a>, <a class="bk_pop" href="#cdg.REF.eklund.2005b.847">Eklund et al 2005b</a>, <a class="bk_pop" href="#cdg.REF.h_ck.2015.73">H&#x000f6;ck et al 2015</a>].</p><p><b>ALG2-CDG (<i>CDG-Ii</i>).</b> An individual age six years had bilateral iris colobomas, unilateral cataract, infantile spasms beginning at age four months, and severe developmental delay; coagulation factors were abnormal [<a class="bk_pop" href="#cdg.REF.thiel.2003.22498">Thiel et al 2003</a>].</p><p><b>DPAGT1-CDG (<i>CDG-Ij</i>)</b> is characterized by hypotonia, intractable seizures, developmental delay, skeletal anomalies, and microcephaly [<a class="bk_pop" href="#cdg.REF.carrera.2012.2027">Carrera et al 2012</a>, <a class="bk_pop" href="#cdg.REF.timal.2012.4151">Timal et al 2012</a>, <a class="bk_pop" href="#cdg.REF.w_rde.2012.634">W&#x000fc;rde et al 2012</a>].</p><p><b>ALG1-CDG (<i>CDG-Ik</i>).</b> The phenotypic spectrum ranges from mild intellectual disability to death in the first few weeks of life [<a class="bk_pop" href="#cdg.REF.ng.2016.653">Ng et al 2016</a>]. Features may include severe developmental delay, rapidly progressive microcephaly, hypotonia, early-onset seizures, severe coagulation defects, immunodeficiency, nephrotic syndrome, liver dysfunction, and cardiomyopathy [<a class="bk_pop" href="#cdg.REF.schwarz.2004.472">Schwarz et al 2004</a>, <a class="bk_pop" href="#cdg.REF.dupr_.2010.729">Dupr&#x000e9; et al 2010</a>].</p><p><b>ALG9-CDG (<i>CDG-IL</i>).</b> Features may include microcephaly, hypotonia, developmental delay, seizures, hepatomegaly, pericardial effusion, renal cysts, and skeletal dysplasia. Brain MRI may demonstrate cerebral atrophy and delayed myelination [<a class="bk_pop" href="#cdg.REF.frank.2004.146">Frank et al 2004</a>, <a class="bk_pop" href="#cdg.REF.weinstein.2005.194">Weinstein et al 2005</a>, <a class="bk_pop" href="#cdg.REF.alsubhi.2016.107">AlSubhi et al 2016</a>].</p><p><b>DOLK-CDG (<i>CDG-Im</i>).</b> Dilated cardiomyopathy in combination with a muscular dystrophy <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#cdg.REF.lefeber.2011.e1002427">Lefeber et al 2011</a>], a purely neurologic phenotype [<a class="bk_pop" href="#cdg.REF.helander.2013.342">Helander et al 2013</a>], and a severe fatal multiple system syndrome have been described [<a class="bk_pop" href="#cdg.REF.lieu.2013.484">Lieu et al 2013</a>]. Features may include hypotonia, ichthyosis, seizures, and progressive microcephaly.</p><p><b>RFT1-CDG (<i>CDG-In</i>).</b> Common features include severe developmental delay, hypotonia, visual disturbances, seizures, feeding difficulties, sensorineural hearing loss, inverted nipples, and microcephaly [<a class="bk_pop" href="#cdg.REF.jaeken.2009b.s335">Jaeken et al 2009b</a>, <a class="bk_pop" href="#cdg.REF.vleugels.2009.1428">Vleugels et al 2009</a>]. Two adult sibs had severe cognitive impairment and controlled seizures; neither had visual impairment [<a class="bk_pop" href="#cdg.REF.ondruskova.2012.760">Ondruskova et al 2012</a>].</p><p><b>DPM3-CDG (<i>CDG-Io</i>).</b> A single described individual diagnosed at age 27 years had a low normal IQ and mild muscle weakness. She presented initially at age 11 years with mild muscle weakness and waddling gait. She was found to have dilated cardiomyopathy without signs of cardiac muscle hypertrophy at age 20 years followed by a stroke-like episode at age 21 years [<a class="bk_pop" href="#cdg.REF.lefeber.2009.76">Lefeber et al 2009</a>].</p><p><b>ALG11-CDG (<i>CDG-Ip</i>).</b> Features include developmental delay, strabismus, and seizures [<a class="bk_pop" href="#cdg.REF.thiel.2012.485">Thiel et al 2012</a>]. One infant developed an unusual fat pattern around age six months [<a class="bk_pop" href="#cdg.REF.rind.2010.1413">Rind et al 2010</a>]; she had persistent vomiting and gastric bleeding and died at age two years.</p><p><b>SRD5A3-CDG (<i>CDG-Iq</i>).</b> Common features including <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> eye malformations (ocular coloboma, optic nerve hypoplasia, and variable degree of visual loss), nystagmus, hypotonia, developmental delay/intellectual disability, and cerebellar ataxia. Less commonly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have dermatologic complications and/or congenital heart defects [<a class="bk_pop" href="#cdg.REF.cantagrel.2010.203">Cantagrel et al 2010</a>, <a class="bk_pop" href="#cdg.REF.morava.2010.3210">Morava et al 2010</a>].</p><p>Note: Biallelic pathogenic variants in <i>SRD5A3</i> have also been identified in people with Kahrizi syndrome, an allelic disorder characterized by coloboma, cataract, kyphosis, and intellectual disability [<a class="bk_pop" href="#cdg.REF.kahrizi.2011.115">Kahrizi et al 2011</a>].</p><p><b>DDOST-CDG (<i>CDG-Ir</i>).</b> A single child was described, presenting with failure to thrive, developmental delay, hypotonia, strabismus and hepatic dysfunction. At three years the child walked but continued to have fine motor delays and minimal speech development. Brain MRI showed dysmyelination [<a class="bk_pop" href="#cdg.REF.jones.2012.363">Jones et al 2012</a>].</p><p><b>MAGT1-CDG</b> was reported in a family with two girls with mild cognitive impairment and two boys with more severe cognitive involvement. The mother is reported to have mild cognitive impairment [<a class="bk_pop" href="#cdg.REF.molinari.2008.1150">Molinari et al 2008</a>].</p><p><b>TUSC3-CDG</b> has been described in 12 individuals (including 2 French sibs and 3 Iranian sibs) with nonsyndromic moderate-to-severe cognitive impairment and normal brain MRI [<a class="bk_pop" href="#cdg.REF.garshasbi.2011.1976">Garshasbi et al 2011</a>].</p><p><b>ALG13-CDG</b> was described in one child with microcephaly, hepatomegaly, edema of the extremities, intractable seizures, recurrent infections and increased bleeding tendency who died at age one year [<a class="bk_pop" href="#cdg.REF.timal.2012.4151">Timal et al 2012</a>].</p><p><b>PGM1-CDG.</b> Features may include dilated cardiomyopathy, chronic hepatitis, fatigue, and Pierre Robin sequence with cleft palate [<a class="bk_pop" href="#cdg.REF.timal.2012.4151">Timal et al 2012</a>].</p><p>Note: Biallelic pathogenic variants in <i>PGM1</i> have also been described in an individual with a clinical diagnosis of glycogen storage disease type 14 with recurrent rhabdomyolysis [<a class="bk_pop" href="#cdg.REF.stojkovic.2009.425">Stojkovic et al 2009</a>].</p><p><b>STT3A-CDG (<i>CDG-Iw</i>).</b> Two sibs have been described with microcephaly, cognitive impairment, failure to thrive, seizures, and cerebellar atrophy [<a class="bk_pop" href="#cdg.REF.shrimal.2013.4638">Shrimal et al 2013</a>].</p><p><b>STT3B-CDG (<i>CDG-Ix</i>).</b> A single individual with microcephaly, severe developmental delay, failure to thrive, seizure disorder, and liver and genitourinary abnormalities has been described [<a class="bk_pop" href="#cdg.REF.shrimal.2013.4638">Shrimal et al 2013</a>].</p><p><b>SSR4-CDG (<i>CDG-Iy</i>)</b> is an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> disorder in which males have microcephaly, cognitive impairment, and seizure disorder. Other features may include feeding issues with oral aversion, failure to thrive, and distinctive facial features. Less commonly, skeletal, hematologic, cardiac, and renal abnormalities have been described [<a class="bk_pop" href="#cdg.REF.ng.2015.1048">Ng et al 2015</a>].</p><p><b>MGAT2-CDG (<i>CDG-IIa</i>).</b> Individuals have facial dysmorphism, stereotypic hand movements, seizures, and varying degrees of developmental delay, but no peripheral neuropathy or cerebellar hypoplasia. A bleeding disorder is caused by diminished platelet aggregation [<a class="bk_pop" href="#cdg.REF.van_geet.2001.477">Van Geet et al 2001</a>].</p><p><b>MOGS-CDG (<i>CDG-IIb</i>).</b> Findings include distinctive facial features, generalized hypotonia, cognitive impairment, seizures, abnormal brain imaging, hearing loss, and recurrent infections along with hypogammaglobulinemia [<a class="bk_pop" href="#cdg.REF.sadat.2014.1615">Sadat et al 2014</a>]. One infant also had hypoplastic genitalia, feeding difficulties, hypoventilation, and generalized edema [<a class="bk_pop" href="#cdg.REF.de_praeter.2000.1744">De Praeter et al 2000</a>].</p><p><b>SLC35C1-CDG (<i>CDG-IIc</i>).</b> Severe growth and developmental delay, microcephaly, hypotonia, distinctive facial l features, and recurrent bacterial infections with persistent, highly elevated peripheral blood leukocyte count are characteristic [<a class="bk_pop" href="#cdg.REF.etzioni.2002.131">Etzioni et al 2002</a>].</p><p><b>B4GALT1-CDG (<i>CDG-IId</i>).</b> Mild developmental delay, Dandy-Walker malformation, progressive hydrocephalus, coagulation abnormalities, and elevated serum creatine kinase concentration have been observed [<a class="bk_pop" href="#cdg.REF.peters.2002.27">Peters et al 2002</a>].</p><p><b>SLC35A2-CDG</b> is an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> disorder leading to severe early-onset encephalopathy [<a class="bk_pop" href="#cdg.REF.kodera.2013.1708">Kodera et al 2013</a>].</p><p><b>GMPPA-CDG</b> was identified in several individuals with cognitive impairment and autonomic dysfunction including achalasia and alacrima. Gait abnormalities were also seen [<a class="bk_pop" href="#cdg.REF.koehler.2013.727">Koehler et al 2013</a>].</p></div><div id="cdg.MultiplePathway_Disorders"><h4>Multiple-Pathway Disorders</h4><p><b>COG7-CDG (<i>CDG-IIe</i>).</b> Features include <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> facies with a small mouth (although one had full lips), micro- and retrognathia, short neck, wrinkled and loose skin, adducted thumbs, overlapping long fingers, hypotonia, hepatosplenomegaly and progressive jaundice, seizures, and early death [<a class="bk_pop" href="#cdg.REF.wu.2004.518">Wu et al 2004</a>, <a class="bk_pop" href="#cdg.REF.spaapen.2005.707">Spaapen et al 2005</a>, <a class="bk_pop" href="#cdg.REF.morava.2007.638">Morava et al 2007</a>, <a class="bk_pop" href="#cdg.REF.ng.2007.201">Ng et al 2007</a>].</p><p><b>SLC35A1-CDG (<i>CDG-IIf</i>).</b> One <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> infant presented at age four months with macrothrombocytopenia, neutropenia, and immunodeficiency, and died at age 37 months of complications from bone marrow transplantation [<a class="bk_pop" href="#cdg.REF.martinezduncker.2005.2671">Martinez-Duncker et al 2005</a>].</p><p><b>COG1-CDG (<i>CDG-IIg</i>).</b> An <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> infant presented in the first month of life with feeding difficulties, failure to thrive, and hypotonia. She had mild developmental delays, rhizomelic short stature, and progressive microcephaly with slight cerebral and cerebellar atrophy on brain MRI, as well as cardiac abnormalities and hepatosplenomegaly [<a class="bk_pop" href="#cdg.REF.foulquier.2006.3764">Foulquier et al 2006</a>].</p><p><b>COG2-CDG.</b> A single individual was described with acquired microcephaly, cognitive impairment, seizures and liver dysfunction [<a class="bk_pop" href="#cdg.REF.kodera.2015.455">Kodera et al 2015</a>].</p><p><b>COG8-CDG (<i>CDG-IIh</i>).</b> Two <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> infants with severe developmental delay, hypotonia, seizures, esotropia, failure to thrive, and progressive microcephaly were reported [<a class="bk_pop" href="#cdg.REF.foulquier.2007.717">Foulquier et al 2007</a>, <a class="bk_pop" href="#cdg.REF.kranz.2007b.433">Kranz et al 2007b</a>].</p><p>A pair of sibs who had a milder presentation with pseudo-gynecomastia, hypotonia, intellectual disability, and ataxia were described [<a class="bk_pop" href="#cdg.REF.st_lting.2009.305">St&#x000f6;lting et al 2009</a>].</p><p><b>COG5-CDG (<i>CDG-Iii</i>).</b> Features may include peripheral neuropathy, hepatic dysfunction, and mild cognitive impairment, although more severe cognitive impairment with blindness and deafness has also been described [<a class="bk_pop" href="#cdg.REF.paesoldburda.2009.4350">Paesold-Burda et al 2009</a>, <a class="bk_pop" href="#cdg.REF.rymen.2012.94">Rymen et al 2012</a>].</p><p><b>COG4-CDG (<i>CDG-IIj</i>).</b> Features include severe cognitive impairment, seizures, hypotonia, liver cirrhosis, recurrent infections and early death. Less common features may include microcephaly, ataxia, and brisk uncoordinated movements [<a class="bk_pop" href="#cdg.REF.reynders.2009.3244">Reynders et al 2009</a>, <a class="bk_pop" href="#cdg.REF.ng.2011.364">Ng et al 2011</a>].</p><p><b>TMEM165-CDG (<i>CDGIIk</i>).</b> Sibs with a skeletal dysplasia affecting the epiphyses, metaphyses, and diaphyse were described. Additional features included abnormal white matter and pituitary hypoplasia on brain MRI [<a class="bk_pop" href="#cdg.REF.foulquier.2012.15">Foulquier et al 2012</a>].</p><p><b>COG6-CDG (<i>CDG-IIL</i>).</b> Features include microcephaly, cognitive impairment, seizures, liver abnormalities, recurrent infections, and ectodermal involvement with hypohidrosis and hyperkeratosis [<a class="bk_pop" href="#cdg.REF.l_bbehusen.2010.3623">L&#x000fc;bbehusen et al 2010</a>, <a class="bk_pop" href="#cdg.REF.rymen.2014.699">Rymen &#x00026; Jaeken 2014</a>].</p><p><b>DHDDS-CDG.</b> Features may include microcephaly, severe developmental delay, liver and renal dysfunction, and severe seizures or retinitis pigmentosa as an isolated finding [<a class="bk_pop" href="#cdg.REF.willer.2012.575">Willer et al 2012</a>, <a class="bk_pop" href="#cdg.REF.sabry.2016.84">Sabry et al 2016</a>].</p><p><b>DPM2-CDG.</b> Failure to thrive, developmental delay, osteopenia, hypotonia, liver dysfunction, increased creatine kinase, and early death have been observed [<a class="bk_pop" href="#cdg.REF.barone.2012.550">Barone et al 2012</a>].</p><p><b>MAN1B1-CDG</b> is characterized by nonsyndromic intellectual disability [<a class="bk_pop" href="#cdg.REF.rafiq.2011.176">Rafiq et al 2011</a>].</p><p><b>PGM3-CDG.</b> Eight individuals with severe atopic dermatitis, recurrent infections due to immunodeficiency, and renal involvement have been described [<a class="bk_pop" href="#cdg.REF.zhang.2014.1400">Zhang et al 2014</a>].</p></div></div></div><div id="cdg.Causes_of_Congenital_Disorders_of_Gl"><h2 id="_cdg_Causes_of_Congenital_Disorders_of_Gl_">Causes of Congenital Disorders of Glycosylation</h2><p>Forty-two different enzymes in the N-linked oligosaccharide synthetic pathway or interactive pathways are currently recognized to be deficient in each of the types of CDG-N-linked or among the multiple-pathway disorders (see <a class="figpopup" href="/books/NBK1332/table/cdg.T.molecular_genetics_of_congenital_d/?report=objectonly" target="object" rid-figpopup="figcdgTmoleculargeneticsofcongenitald" rid-ob="figobcdgTmoleculargeneticsofcongenitald">Table 1</a>).</p><div id="cdg.T.molecular_genetics_of_congenital_d" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetics of Congenital Disorders of Glycosylation</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1332/table/cdg.T.molecular_genetics_of_congenital_d/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cdg.T.molecular_genetics_of_congenital_d_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CDG Type&#x000a0;<sup>1</sup></th><th id="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"># of Cases Reported&#x000a0;<sup>2</sup></th><th id="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>3</sup></th><th id="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Protein&#x000a0;<sup>3</sup></th><th id="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_5" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MOI</th></tr></thead><tbody><tr><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_1 hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_2 hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_3 hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_4 hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_5" colspan="5" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b>CDG-N-Linked</b></td></tr><tr><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">PMM2-CDG (<i>CDG-Ia)</i></td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">700&#x000a0;<sup>4</sup></td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PMM2</i></td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Phosphomannomutase 2</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MPI-CDG (<i>CDG-Ib</i>)</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">20</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MPI</i></td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mannose-6-phosphate isomerase</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ALG6-CDG (<i>CDG-Ic</i>)</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">89</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ALG6</i></td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dolichyl pyrophosphate Man(9)GlcNAc(2)-PP-Dol alpha-1,3-glucosyltransferase</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ALG3-CDG (<i>CDG-Id</i>)</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">11</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ALG3</i></td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DPM1-CDG (<i>CDG-Ie</i>)</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">9</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DPM1</i></td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dolichol-phosphate mannosyltransferase subunit 1</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MPDU1-CDG (<i>CDG-If</i>)</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MPDU1</i></td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mannose-P-dolichol utilization defect 1 protein</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ALG12-CDG (<i>CDG-Ig</i>)</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ALG12</i></td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ALG8-CDG (<i>CDG-Ih</i>)</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ALG8</i></td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ALG2-CDG (<i>CDG-Ii</i>)</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02264;2</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ALG2</i></td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Alpha-1,3/1,6-mannosyltransferase ALG2</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DPAGT1-CDG (<i>CDG-Ij</i>)</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DPAGT1</i></td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ALG1-CDG (<i>CDG-Ik</i>)</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">57</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ALG1</i> (<i>HMT-1</i>)</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Chitobiosyldiphosphodolichol beta-mannosyltransferase</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ALG9-CDG (<i>CDG-IL</i>)</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02264;2</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ALG9</i></td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Alpha-1,2-mannosyltransferase ALG9</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DOLK-CDG (<i>CDG-Im</i>)</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02264;2</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DOLK (DK1)</i></td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dolichol kinase</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">RFT1-CDG (<i>CDG-In</i>)</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">6</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>RFT1</i></td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Protein RFT1 homolog</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DPM3-CDG (<i>CDG-Io</i>)</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02264;2</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DPM3</i></td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dolichol-phosphate mannosyltransferase subunit 3</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ALG11-CDG (<i>CDG-Ip</i>)</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ALG11</i></td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">SRD5A3-CDG (<i>CDG-Iq</i>)</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">15</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SRD5A3</i></td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Polyprenol reductase</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DDOST-CDG (<i>CDG-Ir</i>)</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DDOST</i></td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MAGT1-CDG</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MAGT1</i></td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Magnesium transporter protein 1</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td></tr><tr><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">TUSC3-CDG</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">12</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TUSC3</i></td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Tumor suppressor candidate 3</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ALG13-CDG</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ALG13</i></td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td></tr><tr><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">PGM1-CDG</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PGM1</i></td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Phosphoglucomutase-1</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MGAT2-CDG (<i>CDG-IIa</i>)</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MGAT2</i></td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">STT3A-CDG, STT3B-CDG</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>STT3A, STT3B</i></td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A/STT3B</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">SSR4-CDG</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;2</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SSR4</i></td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Translocon-associated protein subunit delta</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td></tr><tr><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MOGS-CDG (<i>CDG-IIb</i>)</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02264;2</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MOGS (GCS1)</i></td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mannosyl-oligosaccharide glucosidase</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">SLC35C1-CDG (<i>CDG-IIc</i>)</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02264;2</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SLC35C1</i></td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">GDP-fucose transporter 1</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">B4GALT1-CDG (<i>CDG-IId</i>)</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02264;2</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>B4GALT1</i></td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Beta-1,4-galactosyltransferase 1</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">SLC35A2-CDG</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;2</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">SLC35A2</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">UDP-galactose translocator</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td></tr><tr><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">GMPPA-CDG</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;2</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GMPPA</i></td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mannose-1-phosphate guanyltransferase alpha</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_1 hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_2 hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_3 hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_4 hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_5" colspan="5" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Multiple-Pathway Disorders</b></td></tr><tr><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">COG7-CDG (<i>CDG-IIe</i>)</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02264;2</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>COG7</i></td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Conserved oligomeric Golgi complex subunit 7</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">SLC35A1-CDG (<i>CDG-IIf</i>)</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02264;2</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SLC35A1</i></td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CMP-sialic acid transporter</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">COG1-CDG (<i>CDG-IIg</i>)</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02264;2</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>COG1</i></td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Conserved oligomeric Golgi complex subunit 1</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">COG2-CDG</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>COG2</i></td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Conserved oligomeric Golgi complex subunit 2</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">COG8-CDG (<i>CDG-IIh</i>)</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02264;2</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>COG8</i></td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Conserved oligomeric Golgi complex subunit 8</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">COG5-CDG (<i>CDG-IIi</i>)</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>COG5</i></td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Conserved oligomeric Golgi complex subunit 5</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">COG4-CDG (<i>CDG-IIj</i>)</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02264;2</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>COG4</i></td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Conserved oligomeric Golgi complex subunit 4</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">TMEM165-CDG (<i>CDG-IIk</i>)</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TMEM165</i></td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Transmembrane protein 165</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">COG6-CDG (<i>CDG-IIL</i>)</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">17</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>COG6</i></td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Conserved oligomeric Golgi complex subunit 6</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DPM2-CDG</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;2</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DPM2</i></td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dolichol phosphate-mannose biosynthesis regulatory protein</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DHDDS-CDG</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;2</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DHDDS</i></td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dehydrodolichyl diphosphate syntase complex subunit DHDDS</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MAN1B1-CDG</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;2</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MAN1B1</i></td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">PGM3-CDG</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">8</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PGM3</i></td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Phosphoglucomutase 3</td><td headers="hd_h_cdg.T.molecular_genetics_of_congenital_d_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; XL = <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> inheritance</p></div></dd><dt>1. </dt><dd><div id="cdg.TF.1.1"><p class="no_margin">The nomenclature used for CDG types includes a Roman numeral, I or II, and a letter (a-z) [<a class="bk_pop" href="#cdg.REF.aebi.1999.669">Aebi et al 1999</a>]. The Roman numeral is based on transferrin oligosaccharide analytic pattern: Type I and Type II. Letters are assigned in chronologic order of the date of publication of discovery.</p></div></dd><dt>2. </dt><dd><div id="cdg.TF.1.2"><p class="no_margin">Proportion of CDG types as reported in <a class="bk_pop" href="#cdg.REF.jaeken.2010.190">Jaeken [2010]</a></p></div></dd><dt>3. </dt><dd><div id="cdg.TF.1.3"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from <a href="http://www.genenames.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>; protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.</p></div></dd><dt>4. </dt><dd><div id="cdg.TF.1.4"><p class="no_margin">The prevalence of PMM2-CDG (<i>CDG-1a</i>) may be as high as 1:20,000 [<a class="bk_pop" href="#cdg.REF.jaeken.2001.129">Jaeken &#x00026; Matthijs 2001</a>]. The expected <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> frequency of <i>PMM2</i> pathogenic variants in the Danish population is 1:60-1:79 [<a class="bk_pop" href="#cdg.REF.matthijs.2000.386">Matthijs et al 2000</a>].</p></div></dd></dl></div></div></div></div><div id="cdg.Evaluation_Strategy"><h2 id="_cdg_Evaluation_Strategy_">Evaluation Strategy</h2><p><b>The diagnostic test</b> for all N-linked types of CDG is analysis of serum transferrin glycoforms, also called "transferrin <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a> analysis" or "carbohydrate-deficient transferrin analysis." This diagnostic test is performed by <a class="def" href="/books/n/gene/glossary/def-item/isoelectric-focusing/">isoelectric focusing</a> (IEF) or by capillary electrophoresis, GC/MS, CE-ESI-MS, or MALDI-MS to determine the number and presence of incomplete sialylated N-linked oligosaccharide residues linked to serum transferrin [<a class="bk_pop" href="#cdg.REF.jaeken.2001.811">Jaeken &#x00026; Carchon 2001</a>, <a class="bk_pop" href="#cdg.REF.marklov_.2007.6">Marklov&#x000e1; &#x00026; Albahri 2007</a>, <a class="bk_pop" href="#cdg.REF.sanznebot.2007.1949">Sanz-Nebot et al 2007</a>].</p><p>Results of such testing may reveal the following:</p><ul><li class="half_rhythm"><div><b>Normal transferrin isoform pattern.</b> Two biantennary glycans linked to asparagine with four sialic acid residues</div></li><li class="half_rhythm"><div><b>Type I transferrin isoform pattern.</b> Decrease of tetrasialotransferrin and increased asialotransferrin and disialotransferrin. The pattern indicates defects in the earliest synthetic steps of the N-linked oligosaccharide synthetic pathway.</div></li><li class="half_rhythm"><div><b>Type II transferrin isoform pattern.</b> Increased trisialo- and monosialo- fractions, most likely because of the incorporation of truncated or monoantennary sugar chains, defects in the terminal portion of the pathway [<a class="bk_pop" href="#cdg.REF.jaeken.2001.129">Jaeken &#x00026; Matthijs 2001</a>].</div></li></ul><p>Note: (1) The diagnostic validity of analysis of serum transferrin glycoforms before age three weeks is controversial [<a class="bk_pop" href="#cdg.REF.clayton.1992.857">Clayton et al 1992</a>, <a class="bk_pop" href="#cdg.REF.stibler.1994.71">Stibler &#x00026; Skovby 1994</a>]. (2) The use of Guthrie cards with whole blood samples is not suggested; however, the use of Guthrie cards with blotted serum yields accurate results [<a class="bk_pop" href="#cdg.REF.carchon.2006.774">Carchon et al 2006</a>]. (3) Rarely, individuals with the diagnosis of PMM enzyme deficiency with normal transferrin glycosylation have been reported [<a class="bk_pop" href="#cdg.REF.fletcher.2000.396">Fletcher et al 2000</a>, <a class="bk_pop" href="#cdg.REF.marquardt.2003.359">Marquardt &#x00026; Denecke 2003</a>, <a class="bk_pop" href="#cdg.REF.hahn.2006.235">Hahn et al 2006</a>]. (4) Results are expected to be normal in MOGS-CDG (<i>CDG-IIb</i>) and SLC35C1-CDG (<i>CDG-IIc</i>). (5) The possibility that an abnormal transferrin glycoform analysis is the result of a transferrin protein variant can be confirmed with a glycoform analysis of a serum sample from the parents.</p><div id="cdg.Molecular_Genetic_Testing"><h3>Molecular Genetic Testing</h3><p>The type of CDG is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by the identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants (or a <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in a male with an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> CGD) in one of the 44 known CDG-associated genes (see <a class="figpopup" href="/books/NBK1332/table/cdg.T.molecular_genetics_of_congenital_d/?report=objectonly" target="object" rid-figpopup="figcdgTmoleculargeneticsofcongenitald" rid-ob="figobcdgTmoleculargeneticsofcongenitald">Table 1</a>).</p><p>If previous biochemical testing is not diagnostic for or suggestive of a particular CDG, molecular testing approaches most often involve use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> or <b>more</b>
<b>comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>.</p><p>Note: Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing, such as sequencing of <i>PMM2</i>, <i>MP1</i>, and a few other genes, is available for individuals with abnormal transferrin results and a strong clinical suspicion for a specific CGD subtype.</p><p><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes some or all of the 44 genes discussed in this <i>GeneReview</i> may be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this GeneReview; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p><p><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a> may be considered if the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> alone is insufficient to support <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing or if use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> that includes some or all of the genes listed in <a class="figpopup" href="/books/NBK1332/table/cdg.T.molecular_genetics_of_congenital_d/?report=objectonly" target="object" rid-figpopup="figcdgTmoleculargeneticsofcongenitald" rid-ob="figobcdgTmoleculargeneticsofcongenitald">Table 1</a> fails to confirm a diagnosis in an individual with abnormal serum transferrin and clinical features of CDG. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different gene or genes that results in a similar clinical presentation).</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><p><b>Exome array</b> (when clinically available) may be considered if <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> is not diagnostic, particularly when the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is male and <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> or <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> of an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> could explain the clinical features.</p></div></div><div id="cdg.Management"><h2 id="_cdg_Management_">Management</h2><div id="cdg.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p><b>For all <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> disorders of N-linked glycosylation and most multiple-pathway disorders except MPI-CDG (<i>CDG-Ib</i>)</b></p><ul><li class="half_rhythm"><div><b>Failure to thrive.</b> Infants and children can be fed any type of formula for maximal caloric intake. They can tolerate carbohydrates, fats, and protein. Early in life, children may do better on elemental formulas. Their feeding may be advanced based on their oral motor function. Some children require placement of a nasogastric tube or gastrostomy tube for nutritional support until oral motor skills improve.</div></li><li class="half_rhythm"><div><b>Oral motor dysfunction with persistent vomiting.</b> Thickening of feeds, maintenance of an upright position after eating, and antacids can be helpful for children with gastroesophageal reflux and/or persistent vomiting. Consultation with a gastroenterologist and nutritionist is often necessary. Children with a gastrostomy tube should be encouraged to eat by mouth if the risk of aspiration is low. Continued speech and oral motor therapy aids transition to oral feeds and encourages speech when the child is developmentally ready.</div></li><li class="half_rhythm"><div><b>Developmental delay.</b> Occupational therapy, physical therapy, and speech therapy should be instituted. As the developmental gap widens between children with CDG and their unaffected peers, parents, educators, and therapists need continued counseling and support.</div></li><li class="half_rhythm"><div><b>"Infantile catastrophic phase."</b> Very rarely, infants may have a complicated early course presenting with infection, seizure, or hypoalbuminemia with third spacing that may progress to anasarca. Some children are responsive to aggressive albumin replacement with Lasix<sup>&#x000ae;</sup>; others may have a more refractory course. Symptomatic treatment in a pediatric tertiary care center is recommended. Parents should also be advised that some infants with PMM2-CDG (<i>CDG-Ia</i>) never experience a hospital visit while others may require frequent hospitalizations.</div></li><li class="half_rhythm"><div><b>Strabismus.</b> Consultation with a pediatric ophthalmologist early in life is important so that potential eye abnormalities can be diagnosed and therapies that preserve vision (glasses, patching, or surgery) can be instituted as needed.</div></li><li class="half_rhythm"><div><b>Hypothyroidism.</b> Although children with CDG are usually chemically euthyroid [<a class="bk_pop" href="#cdg.REF.martin.2003.67r">Martin &#x00026; Freeze 2003</a>], thyroid function tests are frequently abnormal. However, free thyroxine analyzed by equilibrium dialysis, the most accurate method, has been reported as normal in seven individuals with CDG. Diagnosis of hypothyroidism and L-thyroxine supplementation should be reserved for those children and adults with elevated TSH and low free thyroxine measured by equilibrium dialysis.</div></li><li class="half_rhythm"><div><b>Renal issues.</b> Bilateral hyperechoic kidneys are often seen on ultrasound in children with PMM2-CDG (<i>CDG-Ia</i>). Enlarged kidneys, renal cysts, and <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> nephrotic syndrome have been reported in individuals with PMM2-CDG (<i>CDG-Ia</i>) and other forms of CDG.</div><ul><li class="half_rhythm"><div>Baseline renal ultrasound should be performed on all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children at the time of diagnosis [<a class="bk_pop" href="#cdg.REF.gr_newald.2009.827">Gr&#x000fc;newald 2009</a>, <a class="bk_pop" href="#cdg.REF.sinha.2009.2591">Sinha et al 2009</a>].</div></li><li class="half_rhythm"><div>While proteinuria in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children is extremely rare, routine urinalysis to evaluate for proteinuria is recommended after diagnosis. Follow-up urinalysis should be considered in the first three years of life or if clinical signs indicate.</div></li></ul></li><li class="half_rhythm"><div><b>Stroke-like episodes.</b> Supportive therapy includes intravenous hydration, maintenance of normal blood glucose, and physical therapy during the recovery period.</div></li><li class="half_rhythm"><div><b>Coagulopathy.</b> Low levels of coagulation factors, both pro- and anticoagulant, rarely cause clinical problems in daily activities but must be addressed when an individual with CDG undergoes surgery. Consultation with a hematologist is recommended to document the pro- and anti- clotting factor levels and coagulation status. Discussion of the coagulation status and management issues with the surgeon is important. When necessary, infusion of fresh frozen plasma corrects the factor deficiency and clinical bleeding. The potential for imbalance of the level of both pro- and anticoagulant factors may lead to either bleeding or thrombosis. Care givers, especially of older <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, should be taught the signs of deep venous thrombosis, which can occasionally be mistaken for injury from trauma in individuals with intellectual and communication disabilities.</div></li><li class="half_rhythm"><div><b>Immunologic status.</b> Most individuals <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> with CDGs have functional immune systems; however, children with rare types of N-linked CDG have recurrent or unexpectedly severe infections and should be evaluated by an immunologist. Unless otherwise indicated, full pediatric vaccinations are recommended for affected children and adults.</div></li></ul><p><b>Additional management issues of adults with CDG</b></p><ul><li class="half_rhythm"><div><b>Orthopedic issues &#x02014; thorax shortening, scoliosis/kyphosis.</b> Management involves appropriate orthopedic and physical medicine management, well-supported wheel chairs, appropriate transfer devices for the home, and physical therapy. Occasionally, surgical treatment of spinal curvature by an experienced team is warranted.</div></li><li class="half_rhythm"><div><b>Independent living issues.</b> Young adults with CDG and their parents need to address issues of independent living. Aggressive education in functional life skills and/or vocational training help the transition when schooling is completed. Independence in self-care and the activities of daily living should be encouraged. Support and resources for parents of a disabled adult are important aspects of management.</div></li><li class="half_rhythm"><div><b>Deep venous thrombosis (DVT).</b> DVT has been reported in several adults with PMM2-CDG (<i>CDG-Ia</i>) and MPI-CDG (<i>CDG-Ib</i>) and should be kept in mind in the management of all individuals with CDG. Rapid diagnosis and treatment of DVT are essential to minimize the risk of pulmonary emboli; sedentary <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> adults and children are at increased risk for DVT.</div></li></ul></div><div id="cdg.Prevention_of_Primary_Manifestations"><h3>Prevention of Primary Manifestations</h3><p>MPI-CDG (<i>CDG-Ib</i>), characterized by hepatic-intestinal disease, is the most common type of CDG for which therapy exists. Because so few individuals have been treated and the natural history of this disorder is variable, careful monitoring and discussion among physicians treating these individuals are warranted [<a class="bk_pop" href="#cdg.REF.jaeken.1998.1535">Jaeken et al 1998</a>, <a class="bk_pop" href="#cdg.REF.niehues.1998.1414">Niehues et al 1998</a>, <a class="bk_pop" href="#cdg.REF.de_lonlay.1999.379">de Lonlay et al 1999</a>, <a class="bk_pop" href="#cdg.REF.hendriksz.2001.339">Hendriksz et al 2001</a>, <a class="bk_pop" href="#cdg.REF.de_lonlay.2009.841">de Lonlay &#x00026; Seta 2009</a>]:</p><ul><li class="half_rhythm"><div>In the first reported case, mannose normalized hypoproteinemia and coagulation defects and rapidly improved the protein-losing enteropathy and hypoglycemia [<a class="bk_pop" href="#cdg.REF.harms.2002.1065">Harms et al 2002</a>]. One gram of mannose per kg body weight was given per day, divided into five oral doses.</div></li><li class="half_rhythm"><div>In two children with MPI-CDG (<i>CDG-Ib</i>) treated from infancy with mannose, protein-losing enteropathy and vomiting improved significantly; however, the two children were recently reported to have progressive liver fibrosis [<a class="bk_pop" href="#cdg.REF.mention.2008.40">Mention et al 2008</a>].</div></li><li class="half_rhythm"><div>Recurrent episodes of thromboembolism and consumptive coagulopathy did not recur in an individual with MPI-CDG (<i>CDG-Ib</i>) treated with mannose [<a class="bk_pop" href="#cdg.REF.tamminga.2008.762">Tamminga et al 2008</a>].</div></li><li class="half_rhythm"><div>For some individuals with MPI-CDG (<i>CDG-Ib</i>), heparin therapy can be an alternative to mannose in the treatment of the enteropathy [<a class="bk_pop" href="#cdg.REF.de_lonlay.2009.841">de Lonlay &#x00026; Seta 2009</a>].</div></li><li class="half_rhythm"><div>A woman age 28 years with MPI-CDG (<i>CDG-Ib</i>) developed progressive liver fibrosis despite mannose treatment and heparin therapy and had a successful liver transplant with resolution of her symptoms for at least two years post transplant [<a class="bk_pop" href="#cdg.REF.janssen.2014.e279">Janssen et al 2014</a>].</div></li></ul></div><div id="cdg.Prevention_of_Secondary_Complication"><h3>Prevention of Secondary Complications</h3><p>Because infants with CDG have more limited reserves than their peers, parents should have a low threshold for evaluation by a physician for prolonged fever, vomiting, or diarrhea. Aggressive intervention with antipyretics, antibiotics (if warranted), and hydration may prevent stroke-like episodes, seizures in children with potentially lower seizure threshold as well as the morbidity associated with the "infantile catastrophic phase."</p></div><div id="cdg.Surveillance"><h3>Surveillance</h3><p><b>Annual</b></p><ul><li class="half_rhythm"><div>Assessment by a physician with attention to overall health and possible need for referral for speech, occupational, and physical therapy</div></li><li class="half_rhythm"><div>Eye examination</div></li><li class="half_rhythm"><div>Liver function tests; thyroid panel; serum concentrations of the clotting factors protein C, protein S, factor IX, and antithrombin III</div></li></ul><p><b>Other</b></p><ul><li class="half_rhythm"><div>Periodic assessment of bleeding and clotting parameters by a hematologist</div></li><li class="half_rhythm"><div>Follow up with an orthopedist when scoliosis becomes evident</div></li></ul></div><div id="cdg.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Acetominophen and other agents metabolized by the liver should be used with caution.</p></div><div id="cdg.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to evaluate apparently asymptomatic older and younger sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> in order to identify as early as possible those who would benefit from prompt initiation of treatment (in the treatable forms of N-linked CDG) and those who require developmental monitoring and medical management.</p><p>Evaluations can include:</p><ul><li class="half_rhythm"><div>Molecular genetic testing if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) in the family are known;</div></li><li class="half_rhythm"><div>Serum transferrin analysis if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) in the family are not known and transferrin was abnormal in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</div></li></ul><p>See <a href="#cdg.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="cdg.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>In one individual with SLC35C1-CDG (<i>CDG-IIc</i>), fucose improved the fucosylation of glycoproteins and reduced recurrent infections [<a class="bk_pop" href="#cdg.REF.marquardt.1999.3976">Marquardt et al 1999</a>].</p><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions.</p></div></div><div id="cdg.Genetic_Counseling"><h2 id="_cdg_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="cdg.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Most <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> disorders of N-linked glycosylation and multiple pathway (CDG-N-linked) are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. MGAT1-CDG, ALG13-CDG, SLC35A2-CDG, and SSR4-CDG are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner.</p></div><div id="cdg.Risk_to_Family_Members__Autosomal_Re"><h3>Risk to Family Members &#x02013; Autosomal Recessive Inheritance</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes (i.e., carriers of one <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. See, however, <a href="#cdg.Related_Genetic_Counseling_Issues">Related Genetic Counseling Issues</a>, <b>Increased <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> for PMM2-CDG (<i>CDG-Ia</i></b>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Adults with CDG &#x02013; except for those with MPI-CDG (<i>CDG-Ib</i>) &#x02013; have not been reported to reproduce. (One woman with MPI-CDG (<i>CDG-Ib</i>) had a child without complications.)</div></li><li class="half_rhythm"><div>The offspring of an individual with MPI-CDG (<i>CDG-Ib</i>) are obligate heterozygotes (carriers).</div></li></ul><p><b>Carrier (Heterozygote) Detection</b></p><p>Carrier testing for at-risk relatives requires prior identification of the CDG-N-linked-related pathogenic variants in the family.</p></div><div id="cdg.Risk_to_Family_Members__Xlinked_Inhe"><h3>Risk to Family Members &#x02013; X-linked Inheritance</h3><p><b>Parents of a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The father of a male with MAGT1-CDG, ALG13-CDG, SLC35A2-CDG, or SSR4-CDG will not have the disorder nor will he be <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> for the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>; therefore, he does not require further evaluation/testing.</div></li><li class="half_rhythm"><div>In a family with more than one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual, the mother of an affected male is an <a class="def" href="/books/n/gene/glossary/def-item/obligate-heterozygote/">obligate heterozygote</a> (<a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>). Note: If a woman has more than one affected child and no other affected relatives and if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in her leukocyte DNA, she has <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li><li class="half_rhythm"><div>If a male is the only <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member (i.e., a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case), the mother may be a <a class="def" href="/books/n/gene/glossary/def-item/heterozygote/">heterozygote</a> (<a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>) or the affected male may have a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, in which case the mother is not a carrier. The proportion of affected males representing simplex cases is unknown.</div></li></ul><p><b>Sibs of a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to sibs depends on the genetic status of the mother:</p><ul><li class="half_rhythm"><div>If the mother of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the chance of transmitting it in each pregnancy is 50%. Males who inherit the pathogenic variant will be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>; females who inherit the pathogenic variant will be carriers. There have not been any reported cases of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> female (<a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>) being affected.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> represents a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case (i.e., a single occurrence in a family) and if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in the leukocyte DNA of the mother, the risk to sibs is slightly greater than that of the general population (though still &#x0003c;1%) because of the possibility of maternal <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> To date it is unknown whether <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males can reproduce.</p></div><div id="cdg.Heterozygote_Carrier_Detection"><h3>Heterozygote (Carrier) Detection</h3><p>Molecular genetic testing of at-risk female relatives to determine their genetic status is most informative if the CDG-N-linked-related <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</p></div><div id="cdg.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#cdg.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Increased <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> for PMM2-CDG (<i>CDG-Ia</i>).</b> Studies of the outcomes of prenatal testing suggest that the percentage of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> fetuses is higher than predicted by Mendel's second law. The risk to sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is estimated to be closer to 1/3 than to the expected 1/4. This finding of an apparent increased recurrence risk as a result of transmission ratio distortion continues to be validated [<a class="bk_pop" href="#cdg.REF.schollen.2004b.877">Schollen et al 2004b</a>].</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="cdg.Prenatal_Testing_and_Preimplantation"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) have been identified in the family, <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for a <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> disorder of N-linked glycosylation or multiple pathway are possible.</p></div></div><div id="cdg.Resources"><h2 id="_cdg_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>CDG CARE (Community Alliance and Resource Exchange)</b></div><div><b>Phone:</b> 866-295-7910</div><div><b>Email:</b> info@cdgcare.com</div><div><a href="http://cdgcare.com/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.cdgcare.com</a></div></li><li class="half_rhythm"><div><b>Foundation Glycosylation (FoG)</b></div><div>Canada</div><div><a href="http://www.thefog.ca/main.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.thefog.ca</a></div></li><li class="half_rhythm"><div><b>Portuguese Association CDG and other Rare Metabolic Diseases (APCDG-DMR)</b></div><div>Portugal</div><div><a href="http://www.apcdg.com/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.apcdg.com</a></div></li><li class="half_rhythm"><div><b>Practical Guide to CDG</b></div><div><a href="http://www.apcdg.com/uploads/4/1/1/9/41196831/the_practical_guide_to_cdg_families_fv.compressed.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Practical Guide to CDG</a></div></li></ul></div><div id="cdg.References"><h2 id="_cdg_References_">References</h2><div id="cdg.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.adamowicz.2000.184">Adamowicz M, Matthijs G, Van Schaftingen E, Jaeken J, Rokicki D, Pronicki M. New case of phosphomannose isomerase deficiency (CDG Ib). <span><span class="ref-journal">J Inherit Metab Dis. </span>2000;<span class="ref-vol">23</span> Suppl 1:184.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.aebi.1999.669">Aebi M, Helenius A, Schenk B, Barone R, Fiumara A, Berger EG, Hennet T, Imbach T, Stutz A, Bjursell C, Uller A, Wahlstr&#x000f6;m JG, Briones P, Cardo E, Clayton P, Winchester B, Cormier-Dalre V, de Lonlay P, Cuer M, Dupr&#x000e9; T, Seta N, de Koning T, Dorland L, de Loos F, Kupers L, et al.  Carbohydrate-deficient glycoprotein syndromes become congenital disorders of glycosylation: an updated nomenclature for CDG. First International Workshop on CDGS. <span><span class="ref-journal">Glycoconj J. </span>1999;<span class="ref-vol">16</span>:669–71.</span> [<a href="/pubmed/11003549" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11003549</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.alsubhi.2016.107">AlSubhi S, AlHashem A, AlAzami A, et al.  Further delineation of the Alg9-CDG phenotype. <span><span class="ref-journal">JIMD Rep. </span>2016;<span class="ref-vol">27</span>:107–12.</span> [<a href="/pmc/articles/PMC4867846/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4867846</span></a>] [<a href="/pubmed/26453364" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26453364</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.babovicvuksanovic.1999.775">Babovic-Vuksanovic D, Patterson MC, Schwenk WF, O'Brien JF, Vockley J, Freeze HH, Mehta DP, Michels VV. Severe hypoglycemia as a presenting symptom of carbohydrate-deficient glycoprotein syndrome. <span><span class="ref-journal">J Pediatr. </span>1999;<span class="ref-vol">135</span>:775–81.</span> [<a href="/pubmed/10586187" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10586187</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.barone.2007.107">Barone R, Sturiale L, Fiumara A, Uziel G, Garozzo D, Jaeken J. Borderline mental development in a congenital disorder of glycosylation (CDG) type Ia patient with multisystemic involvement (intermediate phenotype). <span><span class="ref-journal">J Inherit Metab Dis. </span>2007;<span class="ref-vol">30</span>:107.</span> [<a href="/pubmed/17186415" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17186415</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.barone.2012.550">Barone R, Aiello C, Race V, Morava E, Foulquier F, Riemersma M, Passarelli C, Concolino D, Carella M, Santorelli F, Vleugels W, Mercuri E, Garozzo D, Sturiale L, Messina S, Jaeken J, Fiumara A, Wevers RA, Bertini E, Matthijs G, Lefeber DJ. DPM2-CDG: A muscular dystrophy-dystroglycanopathy syndrome with severe epilepsy. <span><span class="ref-journal">Ann Neurol. </span>2012;<span class="ref-vol">72</span>:550–8.</span> [<a href="/pubmed/23109149" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23109149</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.bursle.2017.27">Bursle C, Brown D, Cardinal J, Connor F, Calvert S, Coman D. DMP1-CDG (CDG1e) with significant gastrointestinal manifestations; phenotype and genotype expansion. <span><span class="ref-journal">JIMD Rep. </span>2017;<span class="ref-vol">34</span>:27–32.</span> [<a href="/pmc/articles/PMC5509558/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5509558</span></a>] [<a href="/pubmed/27481510" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27481510</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.cantagrel.2010.203">Cantagrel V, Lefeber DJ, Ng BG, Guan Z, Silhavy JL, Bielas SL, Lehle L, Hombauer H, Adamowicz M, Swiezewska E, De Brouwer AP, Bl&#x000fc;mel P, Sykut-Cegielska J, Houliston S, Swistun D, Ali BR, Dobyns WB, Babovic-Vuksanovic D, van Bokhoven H, Wevers RA, Raetz CR, Freeze HH, Morava E, Al-Gazali L, Gleeson JG. SRD5A3 is required for converting polyprenol to dolichol and is mutated in a congenital glycosylation disorder. <span><span class="ref-journal">Cell. </span>2010;<span class="ref-vol">142</span>:203–17.</span> [<a href="/pmc/articles/PMC2940322/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2940322</span></a>] [<a href="/pubmed/20637498" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20637498</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.carchon.2006.774">Carchon HA, Nsibu Ndosimao C, Van Aerschot S, Jaeken J. Use of serum on Guthrie cards in screening for congenital disorders of glycosylation. <span><span class="ref-journal">Clin Chem. </span>2006;<span class="ref-vol">52</span>:774–5.</span> [<a href="/pubmed/16595835" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16595835</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.carrera.2012.2027">Carrera IA, Matthijs G, Perez B, Cerda CP. DPAGT1-CDG: Report of a patient with fetal hypokinesia phenotype. <span><span class="ref-journal">Am J Med Genet A. </span>2012;<span class="ref-vol">158A</span>:2027–30.</span> [<a href="/pubmed/22786653" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22786653</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.chantret.2003.9962">Chantret I, Dancourt J, Dupre T, Delenda C, Bucher S, Vuillaumier-Barrot S, Ogier de Baulny H, Peletan C, Danos O, Seta N, Durand G, Oriol R, Codogno P, Moore SE. A deficiency in dolichyl-P-glucose:Glc1Man9GlcNAc2-PP-dolichyl alpha3-glucosyltransferase defines a new subtype of congenital disorders of glycosylation. <span><span class="ref-journal">J Biol Chem. </span>2003;<span class="ref-vol">278</span>:9962–71.</span> [<a href="/pubmed/12480927" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12480927</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.chantret.2002.25815">Chantret I, Dupre T, Delenda C, Bucher S, Dancourt J, Barnier A, Charollais A, Heron D, Bader-Meunier B, Danos O, Seta N, Durand G, Oriol R, Codogno P, Moore SE. Congenital disorders of glycosylation type Ig is defined by a deficiency in dolichyl-P-mannose:Man7GlcNAc2-PP-dolichyl mannosyltransferase. <span><span class="ref-journal">J Biol Chem. </span>2002;<span class="ref-vol">277</span>:25815–22.</span> [<a href="/pubmed/11983712" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11983712</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.clayton.1992.857">Clayton PT, Winchester BG, Keir G. Hypertrophic obstructive cardiomyopathy in a neonate with the carbohydrate-deficient glycoprotein syndrome. <span><span class="ref-journal">J Inherit Metab Dis. </span>1992;<span class="ref-vol">15</span>:857–61.</span> [<a href="/pubmed/1293380" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1293380</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.coman.2007.668">Coman D, McGill J, MacDonald R, Morris D, Klingberg S, Jaeken J, Appleton D. Congenital disorder of glycosylation type 1a: Three siblings with a mild neurological phenotype. <span><span class="ref-journal">J Clin Neurosci. </span>2007;<span class="ref-vol">14</span>:668–72.</span> [<a href="/pubmed/17451957" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17451957</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.dancourt.2006.835">Dancourt J, Vuillaumier-Barrot S, de Baulny HO, Sfaello I, Barnier A, le Bizec C, Dupre T, Durand G, Seta N, Moore SE. A new intronic mutation in the DPM1 gene is associated with a milder form of CDG Ie in two French siblings. <span><span class="ref-journal">Pediatr Res. </span>2006;<span class="ref-vol">59</span>:835–9.</span> [<a href="/pubmed/16641202" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16641202</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.de_koning.1998.38">de Koning TJ, Dorland L, van Diggelen OP, Boonman AM, de Jong GJ, van Noort WL, De Schryver J, Duran M, van den Berg IE, Gerwig GJ, Berger R, Poll-The BT. A novel disorder of N-glycosylation due to phosphomannose isomerase deficiency. <span><span class="ref-journal">Biochem Biophys Res Commun. </span>1998;<span class="ref-vol">245</span>:38–42.</span> [<a href="/pubmed/9535779" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9535779</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.de_lonlay.1999.379">de Lonlay P, Cuer M, Vuillaumier-Barrot S, Beaune G, Castelnau P, Kretz M, Durand G, Saudubray JM, Seta N. Hyperinsulinemic hypoglycemia as a presenting sign in phosphomannose isomerase deficiency: A new manifestation of carbohydrate-deficient glycoprotein syndrome treatable with mannose. <span><span class="ref-journal">J Pediatr. </span>1999;<span class="ref-vol">135</span>:379–83.</span> [<a href="/pubmed/10484808" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10484808</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.de_lonlay.2009.841">de Lonlay P, Seta N. The clinical spectrum of phosphomannose isomerase deficiency, with an evaluation of mannose treatment for CDG-Ib. <span><span class="ref-journal">Biochim Biophys Acta. </span>2009;<span class="ref-vol">1792</span>:841–3.</span> [<a href="/pubmed/19101627" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19101627</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.de_praeter.2000.1744">De Praeter CM, Gerwig GJ, Bause E, Nuytinck LK, Vliegenthart JF, Breuer W, Kamerling JP, Espeel MF, Martin JJ, De Paepe AM, Chan NW, Dacremont GA, Van Coster RN. A novel disorder caused by defective biosynthesis of N-linked oligosaccharides due to glucosidase I deficiency. <span><span class="ref-journal">Am J Hum Genet. </span>2000;<span class="ref-vol">66</span>:1744–56.</span> [<a href="/pmc/articles/PMC1378052/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1378052</span></a>] [<a href="/pubmed/10788335" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10788335</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.di_rocco.2005.1162">Di Rocco M, Hennet T, Grubenmann CE, Pagliardini S, Allegri AE, Frank CG, Aebi M, Vignola S, Jaeken J. Congenital disorder of glycosylation (CDG) Ig: report on a patient and review of the literature. <span><span class="ref-journal">J Inherit Metab Dis. </span>2005;<span class="ref-vol">28</span>:1162–4.</span> [<a href="/pubmed/16435218" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16435218</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.dupr_.2010.729">Dupr&#x000e9; T, Vuillaumier-Barrot S, Chantret I, Yay&#x000e9; HS, Le Bizec C, Afenjar A, Altuzarra C, Barn&#x000e9;rias C, Burglen L, de Lonlay P, Feillet F, Napuri S, Seta N, Moore SE. Guanosine diphosphate-mannose:GlcNAc2-PP-dolichol mannosyltransferase deficiency (congenital disorders of glycosylation type Ik): five new patients and seven novel mutations. <span><span class="ref-journal">J Med Genet. </span>2010;<span class="ref-vol">47</span>:729–35.</span> [<a href="/pubmed/20679665" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20679665</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.eklund.2005a.25">Eklund EA, Newell JW, Sun L, Seo NS, Alper G, Willert J, Freeze HH. Molecular and clinical description of the first US patients with congenital disorder of glycosylation Ig. <span><span class="ref-journal">Mol Genet Metab. </span>2005a;<span class="ref-vol">84</span>:25–31.</span> [<a href="/pubmed/15639192" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15639192</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.eklund.2005b.847">Eklund EA, Sun L, Westphal V, Northrop JL, Freeze HH, Scaglia F. Congenital disorder of glycosylation (CDG)-Ih patient with a severe hepato-intestinal phenotype and evolving central nervous system pathology. <span><span class="ref-journal">J Pediatr. </span>2005b;<span class="ref-vol">147</span>:847–50.</span> [<a href="/pubmed/16356445" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16356445</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.etzioni.2002.131">Etzioni A, Sturla L, Antonellis A, Green ED, Gershoni-Baruch R, Berninsone PM, Hirschberg CB, Tonetti M. Leukocyte adhesion deficiency (LAD) type II/carbohydrate deficient glycoprotein (CDG) IIc founder effect and genotype/phenotype correlation. <span><span class="ref-journal">Am J Med Genet. </span>2002;<span class="ref-vol">110</span>:131–5.</span> [<a href="/pubmed/12116250" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12116250</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.fletcher.2000.396">Fletcher JM, Matthijs G, Jaeken J, Van Schaftingen E, Nelson PV. Carbohydrate-deficient glycoprotein syndrome: beyond the screen. <span><span class="ref-journal">J Inherit Metab Dis. </span>2000;<span class="ref-vol">23</span>:396–8.</span> [<a href="/pubmed/10896303" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10896303</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.foulquier.2012.15">Foulquier F, Amyere M, Jaeken J, Zeevaert R, Schollen E, Race V, Bammens R, Morelle W, Rosnoblet C, Legrand D, Demaegd D, Buist N, Cheillan D, Guffon N, Morsomme P, Annaert W, Freeze HH, Van Schaftingen E, Vikkula M, Matthijs G. TMEM165 deficiency causes a congenital disorder of glycosylation. <span><span class="ref-journal">Am J Hum Genet. </span>2012;<span class="ref-vol">91</span>:15–26.</span> [<a href="/pmc/articles/PMC3397274/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3397274</span></a>] [<a href="/pubmed/22683087" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22683087</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.foulquier.2007.717">Foulquier F, Ungar D, Reynders E, Zeevaert R, Mills P, Garcia-Silva MT, Briones P, Winchester B, Morelle W, Krieger M, Annaert W, Matthijs G. A new inborn error of glycosylation due to a Cog8 deficiency reveals a critical role for the Cog1-Cog8 interaction in COG complex formation. <span><span class="ref-journal">Hum Mol Genet. </span>2007;<span class="ref-vol">16</span>:717–30.</span> [<a href="/pubmed/17220172" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17220172</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.foulquier.2006.3764">Foulquier F, Vasile E, Schollen E, Callewaert N, Raemaekers T, Quelhas D, Jaeken J, Mills P, Winchester B, Krieger M, Annaert W, Matthijs G. Conserved oligomeric Golgi complex subunit 1 deficiency reveals a previously uncharacterized congenital disorder of glycosylation type II. <span><span class="ref-journal">Proc Nat Acad Sci USA. </span>2006;<span class="ref-vol">103</span>:3764–9.</span> [<a href="/pmc/articles/PMC1450151/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1450151</span></a>] [<a href="/pubmed/16537452" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16537452</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.frank.2004.146">Frank CG, Grubenmann CE, Eyaid W, Berger EG, Aebi M, Hennet T. Identification and functional analysis of a defect in the human ALG9 gene: definition of congenital disorder of glycosylation type IL. <span><span class="ref-journal">Am J Hum Genet. </span>2004;<span class="ref-vol">75</span>:146–50.</span> [<a href="/pmc/articles/PMC1181998/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1181998</span></a>] [<a href="/pubmed/15148656" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15148656</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.freeze.2006.537">Freeze HH. Genetic defects in the human glycome. <span><span class="ref-journal">Nat Rev Genet. </span>2006;<span class="ref-vol">7</span>:537–51.</span> [<a href="/pubmed/16755287" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16755287</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.garshasbi.2011.1976">Garshasbi M, Kahrizi K, Hosseini M, Nouri Vahid L, Falah M, Hemmati S, Hu H, Tzschach A, Ropers HH, Najmabadi H, Kuss AW. A novel nonsense mutation in TUSC3 is responsible for non-syndromic autosomal recessive mental retardation in a consanguineous Iranian family. <span><span class="ref-journal">Am J Med Genet. </span>2011;<span class="ref-vol">155A</span>:1976–80.</span> [<a href="/pubmed/21739581" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21739581</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.grubenmann.2002.2331">Grubenmann CE, Frank CG, Kjaergaard S, Berger EG, Aebi M, Hennet T. ALG12 mannosyltransferase defect in congenital disorder of glycosylation type lg. <span><span class="ref-journal">Hum Mol Genet. </span>2002;<span class="ref-vol">11</span>:2331–9.</span> [<a href="/pubmed/12217961" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12217961</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.gr_newald.2007.825">Gr&#x000fc;newald S. Congenital disorders of glycosylation: rapidly enlarging group of (neuro)metabolic disorders. <span><span class="ref-journal">Early Hum Dev. </span>2007;<span class="ref-vol">83</span>:825–30.</span> [<a href="/pubmed/17959325" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17959325</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.gr_newald.2009.827">Gr&#x000fc;newald S. The clinical spectrum of phosphomannomutase 2 deficiency (CDG-Ia). <span><span class="ref-journal">Biochim Biophys Acta. </span>2009;<span class="ref-vol">1792</span>:827–34.</span> [<a href="/pubmed/19272306" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19272306</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.gr_newald.2002.618">Gr&#x000fc;newald S, Matthijs G, Jaeken J. Congenital disorders of glycosylation: a review. <span><span class="ref-journal">Pediatr Res. </span>2002;<span class="ref-vol">52</span>:618–24.</span> [<a href="/pubmed/12409504" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12409504</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.hahn.2006.235">Hahn SH, Minnich SJ, O'Brien JF. Stabilization of hypoglycosylation in a patient with congenital disorder of glycosylation type Ia. <span><span class="ref-journal">J Inherit Metab Dis. </span>2006;<span class="ref-vol">29</span>:235–7.</span> [<a href="/pubmed/16601903" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16601903</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.harms.2002.1065">Harms HK, Zimmer KP, Kurnik K, Bertele-Harms RM, Weidinger S, Reiter K. Oral mannose therapy persistently corrects the severe clinical symptoms and biochemical abnormalities of phosphomannose isomerase deficiency. <span><span class="ref-journal">Acta Paediatr. </span>2002;<span class="ref-vol">91</span>:1065–72.</span> [<a href="/pubmed/12434892" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12434892</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.helander.2013.342">Helander A, St&#x000f6;dberg T, Jaeken J, Matthijs G, Eriksson M, Eggertsen G. Dolichol kinase deficiency (DOLK-CDG) with a purely neurological presentation caused by a novel mutation. <span><span class="ref-journal">Mol Genet Metab. </span>2013;<span class="ref-vol">110</span>:342–4.</span> [<a href="/pubmed/23890587" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23890587</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.hendriksz.2001.339">Hendriksz CJ, McClean P, Henderson MJ, Keir DG, Worthington VC, Imtiaz F, Schollen E, Matthijs G, Winchester BG. Successful treatment of carbohydrate deficient glycoprotein syndrome type 1b with oral mannose. <span><span class="ref-journal">Arch Dis Child. </span>2001;<span class="ref-vol">85</span>:339–40.</span> [<a href="/pmc/articles/PMC1718944/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1718944</span></a>] [<a href="/pubmed/11567948" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11567948</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.h_ck.2015.73">H&#x000f6;ck M, Wegleiter K, Ralser E, Kiechl-Kohlendorfer U, Scholl-B&#x000fc;rgi S, Fauth C, Steichen E, Pichler K, Lefeber DJ, Matthjis G, Keldermans L, Maurer K, Zschocke J, Karall D. ALG8-CDG: novel patients and review of the literature. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2015;<span class="ref-vol">10</span>:73.</span> [<a href="/pmc/articles/PMC4504351/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4504351</span></a>] [<a href="/pubmed/26066342" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26066342</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.ishikawa.2009.240">Ishikawa N, Tajima G, Ono H, Kobayashi M. Different neuroradiological findings during two stroke-like episodes in a patient with congenital disorder of glycosylation type Ia. <span><span class="ref-journal">Brain Dev. </span>2009;<span class="ref-vol">31</span>:240–3.</span> [<a href="/pubmed/18485644" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18485644</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.jaeken.2010.190">Jaeken J. Congenital disorders of glycosylation. <span><span class="ref-journal">Ann N Y Acad Sci. </span>2010;<span class="ref-vol">1214</span>:190–198.</span> [<a href="/pubmed/21175687" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21175687</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.jaeken.2001.811">Jaeken J, Carchon H. Congenital disorders of glycosylation: the rapidly growing tip of the iceberg. <span><span class="ref-journal">Curr Opin Neurol. </span>2001;<span class="ref-vol">14</span>:811–5.</span> [<a href="/pubmed/11723393" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11723393</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.jaeken.2009a.825">Jaeken J, Hennet T, Matthijs G, Freeze H. CDG nomenclature: Time for a Change! <span><span class="ref-journal">Biochim Biophys Acta. </span>2009a;<span class="ref-vol">1792</span>:825–6.</span> [<a href="/pmc/articles/PMC3917312/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3917312</span></a>] [<a href="/pubmed/19765534" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19765534</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.jaeken.2000.186">Jaeken J, Imbach T, et al.  A newly recognized glycosylation defect with psychomotor retardation, ichthyosis and dwarfism. <span><span class="ref-journal">J Inherit Metab Dis. </span>2000;<span class="ref-vol">23</span> Suppl 1:186.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.jaeken.2015">Jaeken J, Lefeber D, Matthijs G. Clinical utility gene card for: ALG6 defective congenital disorder of glycosylation. <span><span class="ref-journal">Eur J Hum Genet. </span>2015 Feb;<span class="ref-vol">23</span>(2)</span> [<a href="/pmc/articles/PMC4297893/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4297893</span></a>] [<a href="/pubmed/25052310" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25052310</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.jaeken.2001.129">Jaeken J, Matthijs G. Congenital disorders of glycosylation. <span><span class="ref-journal">Annu Rev Genomics Hum Genet. </span>2001;<span class="ref-vol">2</span>:129–51.</span> [<a href="/pubmed/11701646" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11701646</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.jaeken.1998.1535">Jaeken J, Matthijs G, Saudubray JM, Dionisi-Vici C, Bertini E, de Lonlay P, Henri H, Carchon H, Schollen E, Van Schaftingen E. Phosphomannose isomerase deficiency: a carbohydrate-deficient glycoprotein syndrome with hepatic-intestinal presentation. <span><span class="ref-journal">Am J Hum Genet. </span>1998;<span class="ref-vol">62</span>:1535–9.</span> [<a href="/pmc/articles/PMC1377152/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1377152</span></a>] [<a href="/pubmed/9585601" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9585601</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.jaeken.2009b.s335">Jaeken J, Vleugels W, R&#x000e9;gal L, Corchia C, Goemans N, Haeuptle MA, Foulquier F, Hennet T, Matthijs G, Dionisi-Vici C. RFT1-CDG: Deafness as a novel feature of congenital disorders of glycosylation. <span><span class="ref-journal">J Inherit Metab Dis. </span>2009b;<span class="ref-vol">32</span> Suppl 1:S335–8.</span> [<a href="/pubmed/19856127" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19856127</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.janssen.2014.e279">Janssen MC, de Kleine RH, van den Berg AP, Heijdra Y, van Scherpenzeel M, Lefeber D, Morava E. Successful liver transplantation and long term follow-up in a patient with MPI-CDG. <span><span class="ref-journal">Pediatrics. </span>2014;<span class="ref-vol">134</span>:e279–83.</span> [<a href="/pubmed/24982104" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24982104</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.jones.2012.363">Jones MA, Ng BG, Bhide S, Chin E, Rhodenizer D, He P, Losfeld ME, He M, Raymond K, Berry G, Freeze HH, Hegde MR. DDOST mutations identified by whole-exome sequencing are implicated in congenital disorders of glycosylation. <span><span class="ref-journal">Am J Hum Genet. </span>2012;<span class="ref-vol">90</span>:363–8.</span> [<a href="/pmc/articles/PMC3276676/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3276676</span></a>] [<a href="/pubmed/22305527" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22305527</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.kahook.2006.115">Kahook MY, Mandava N, Bateman JB, Thomas JA. Glycosylation type Ic disorder: idiopathic intracranial hypertension and retinal degeneration. <span><span class="ref-journal">Br J Ophthalmol. </span>2006;<span class="ref-vol">90</span>:115–6.</span> [<a href="/pmc/articles/PMC1478164/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1478164</span></a>] [<a href="/pubmed/16361681" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16361681</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.kahrizi.2011.115">Kahrizi K, Hu CH, Garshasbi M, Abedini SS, Ghadami S, Kariminejad R, Ullmann R, Chen W, Ropers HH, Kuss AW, Najmabadi H, Tzschach A. Next generation sequencing in a family with autosomal recessive Kahrizi syndrome (OMIM 612713) reveals a homozygous frameshift mutation in SRD5A3. <span><span class="ref-journal">Eur J Hum Genet. </span>2011;<span class="ref-vol">19</span>:115–7.</span> [<a href="/pmc/articles/PMC3039499/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3039499</span></a>] [<a href="/pubmed/20700148" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20700148</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.kodera.2015.455">Kodera H, Ando N, Yuasa I, Wada Y, Tsurusaki Y, Nakashima M, Miyake N, Saitoh S, Matsumoto N, Saitsu H. Mutations in COG2 encoding a subunit of the conserved oligomeric golgi complex cause a congenital disorder of glycosylation. <span><span class="ref-journal">Clin Genet. </span>2015;<span class="ref-vol">87</span>:455–60.</span> [<a href="/pubmed/24784932" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24784932</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.kodera.2013.1708">Kodera H, Nakamura K, Osaka H, Maegaki Y, Haginoya K, Mizumoto S, Kato M, Okamoto N, Iai M, Kondo Y, Nishiyama K, Tsurusaki Y, Nakashima M, Miyake N, Hayasaka K, Sugahara K, Yuasa I, Wada Y, Matsumoto N, Saitsu H. De novo mutations in SLC35A2 encoding a UDP-galactose transporter cause early-onset epileptic encephalopathy. <span><span class="ref-journal">Hum Mutat. </span>2013;<span class="ref-vol">34</span>:1708–14.</span> [<a href="/pubmed/24115232" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24115232</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.koehler.2013.727">Koehler K, Malik M, Mahmood S, Gie&#x000df;elmann S, Beetz C, Hennings JC, Huebner AK, Grahn A, Reunert J, N&#x000fc;rnberg G, Thiele H, Altm&#x000fc;ller J, N&#x000fc;rnberg P, Mumtaz R, Babovic-Vuksanovic D, Basel-Vanagaite L, Borck G, Br&#x000e4;mswig J, M&#x000fc;hlenberg R, Sarda P, Sikiric A, Anyane-Yeboa K, Zeharia A, Ahmad A, Coubes C, Wada Y, Marquardt T, Vanderschaeghe D, Van Schaftingen E, Kurth I, Huebner A, H&#x000fc;bner CA. Mutations in GMPPA cause a glycosylation disorder characterized by intellectual disability and autonomic dysfunction. <span><span class="ref-journal">Am J Hum Genet. </span>2013;<span class="ref-vol">93</span>:727–34.</span> [<a href="/pmc/articles/PMC3791256/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3791256</span></a>] [<a href="/pubmed/24035193" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24035193</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.kranz.2007a.1371">Kranz C, Basinger AA, G&#x000fc;&#x000e7;sava&#x0015f;-Caliko&#x0011f;lu M, Sun L, Powell CM, Henderson FW, Aylsworth AS, Freeze HH. Expanding spectrum of congenital disorder of glycosylation Ig (CDG-Ig): sibs with a unique skeletal dysplasia, hypogammaglobulinemia, cardiomyopathy, genital malformations, and early lethality. <span><span class="ref-journal">Am J Med Genet A. </span>2007a;<span class="ref-vol">143A</span>:1371–8.</span> [<a href="/pubmed/17506107" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17506107</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.kranz.2001.1613">Kranz C, Denecke J, Lehrman MA, Ray S, Kienz P, Kreissel G, Sagi D, Peter-Katalinic J, Freeze HH, Schmid T, Jackowski-Dohrmann S, Harms E, Marquardt T. A mutation in the human MPDU1 gene causes congenital disorder of glycosylation type If (CDG-If). <span><span class="ref-journal">J Clin Invest. </span>2001;<span class="ref-vol">108</span>:1613–9.</span> [<a href="/pmc/articles/PMC200991/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC200991</span></a>] [<a href="/pubmed/11733556" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11733556</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.kranz.2007b.433">Kranz C, Jungeblut C, Denecke J, Erlekotte A, Sohlbach C, Debus V, Kehl HG, Harms E, Reith A, Reichel S, Grobe H, Hammersen G, Schwarzer U, Marquardt T. A defect in dolichol phosphate biosynthesis causes a new inherited disorder with death in early infancy. <span><span class="ref-journal">Am J Hum Genet. </span>2007b;<span class="ref-vol">80</span>:433–40.</span> [<a href="/pmc/articles/PMC1821118/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1821118</span></a>] [<a href="/pubmed/17273964" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17273964</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.lefeber.2011.e1002427">Lefeber DJ, de Brouwer AP, Morava E, Riemersma M, Schuurs-Hoeijmakers JH, Absmanner B, Verrijp K, van den Akker WM, Huijben K, Steenbergen G, van Reeuwijk J, Jozwiak A, Zucker N, Lorber A, Lammens M, Knopf C, van Bokhoven H, Gr&#x000fc;newald S, Lehle L, Kapusta L, Mandel H, Wevers RA. Autosomal recessive dilated cardiomyopathy due to&#x000a0;DOLK&#x000a0;mutations results from abnormal dystroglycan O-mannosylation. <span><span class="ref-journal">PLoS Genet. </span>2011;<span class="ref-vol">7</span>:e1002427.</span> [<a href="/pmc/articles/PMC3248466/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3248466</span></a>] [<a href="/pubmed/22242004" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22242004</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.lefeber.2009.76">Lefeber DJ, Schonberger J, Morave E, Guillard M, Huyben KM, Verrijp J, Grafakou O, Evangeliou A, Preijers FW, Manta P, Yildiz J, Grunewald S, et al.  Deficiency of Dol-P-Man synthase subunit DPM3 bridges the congenital disorders of glycosylation with the dystroglycanopathies. <span><span class="ref-journal">Am J Hum Genet. </span>2009;<span class="ref-vol">85</span>:76–86.</span> [<a href="/pmc/articles/PMC2706967/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2706967</span></a>] [<a href="/pubmed/19576565" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19576565</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.lepais.2015.2748">Lepais L, Cheillan D, Frachon SC, Hays S, Matthijs G, Panagiotakaki E, Abel C, Edery P, Rossi M. ALG3-CDG: Report of two siblings with antenatal features carrying homozygous p.Gly96Arg mutation. <span><span class="ref-journal">Am J Med Genet A. </span>2015;<span class="ref-vol">167A</span>:2748–54.</span> [<a href="/pubmed/26126960" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26126960</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.lieu.2013.484">Lieu MT, Ng BG, Rush JS, Wood T, Basehore MJ, Hegde M, Chang RC, Abdenur JE, Freeze HH, Wang RY. Severe, fatal multisystem manifestations in a patient with dolichol kinase-congenital disorder of glycosylation. <span><span class="ref-journal">Mol Genet Metab. </span>2013;<span class="ref-vol">110</span>:484–9.</span> [<a href="/pmc/articles/PMC3909743/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3909743</span></a>] [<a href="/pubmed/24144945" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24144945</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.l_bbehusen.2010.3623">L&#x000fc;bbehusen J, Thiel C, Rind N, Ungar D, Prinsen BH, de Koning TJ, van Hasselt PM, K&#x000f6;rner C. Fatal outcome due to deficiency of subunit 6 of the conserved oligomeric Golgi complex leading to a new type of congenital disorders of glycosylation. <span><span class="ref-journal">Hum Mol Genet. </span>2010;<span class="ref-vol">19</span>:3623–33.</span> [<a href="/pubmed/20605848" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20605848</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.marklov_.2007.6">Marklov&#x000e1; E, Albahri Z. Screening and diagnosis of congenital disorders of glycosylation. <span><span class="ref-journal">Clin Chim Acta. </span>2007;<span class="ref-vol">385</span>:6–20.</span> [<a href="/pubmed/17716641" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17716641</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.marquardt.2003.359">Marquardt T, Denecke J. Congenital disorders of glycosylation: review of their molecular bases, clinical presentations and specific therapies. <span><span class="ref-journal">Eur J Pediatr. </span>2003;<span class="ref-vol">162</span>:359–79.</span> [<a href="/pubmed/12756558" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12756558</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.marquardt.1999.3976">Marquardt T, Luhn K, Srikrishna G, Freeze HH, Harms E, Vestweber D. Correction of leukocyte adhesion deficiency type II with oral fucose. <span><span class="ref-journal">Blood. </span>1999;<span class="ref-vol">94</span>:3976–85.</span> [<a href="/pubmed/10590041" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10590041</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.martin.2003.67r">Martin PT, Freeze HH. Glycobiology of neuromuscular disorders. <span><span class="ref-journal">Glycobiology. </span>2003;<span class="ref-vol">13</span>:67R–75R.</span> [<a href="/pubmed/12736200" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12736200</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.martinezduncker.2005.2671">Martinez-Duncker I, Dupr&#x000e9; T, Piller V, Piller F, Candelier JJ, Trichet C, Tchernia G, Oriol R, Mollicone R. Genetic complementation reveals a novel human congenital disorder of glycosylation of type II, due to inactivation of the Golgi CMP-sialic acid transporter. <span><span class="ref-journal">Blood. </span>2005;<span class="ref-vol">105</span>:2671–6.</span> [<a href="/pubmed/15576474" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15576474</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.matthijs.2000.386">Matthijs G, Schollen E, Bjursell C, Erlandson A, Freeze H, Imtiaz F, Kjaergaard S, Martinsson T, Schwartz M, Seta N, Vuillaumier-Barrot S, Westphal V, Winchester B. Mutations in PMM2 that cause congenital disorders of glycosylation, type Ia (CDG-Ia). <span><span class="ref-journal">Hum Mutat. </span>2000;<span class="ref-vol">16</span>:386–94.</span> [<a href="/pubmed/11058895" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11058895</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.mention.2008.40">Mention K, Lacaille F, Valayannopoulos V, Romano S, Kuster A, Cretz M, Zaidan H, Galmiche L, Jaubert F, de Keyzer Y, Seta N, de Lonlay P. Development of liver disease despite mannose treatment in two patients with CDG-Ib. <span><span class="ref-journal">Mol Genet Metab. </span>2008;<span class="ref-vol">93</span>:40–3.</span> [<a href="/pubmed/17945525" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17945525</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.miller.2011.101">Miller BS, Freeze HH, Hoffmann GF, Sarafoglou K. Pubertal development in ALG6 deficiency (congenital disorder of glycosylation type Ic). <span><span class="ref-journal">Mol Genet Metab. </span>2011;<span class="ref-vol">103</span>:101–3.</span> [<a href="/pmc/articles/PMC3869397/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3869397</span></a>] [<a href="/pubmed/21334936" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21334936</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.molinari.2008.1150">Molinari F, Foulquier F, Tarpey PS, Morelle W, Boissel S, Teague J, Edkins S, Futreal PA, Stratton MR, Turner G, Matthijs G, Gecz J, Munnich A, Colleaux L. Oligosaccharyltransferase-subunit mutations in nonsyndromic mental retardation. <span><span class="ref-journal">Am. J. Hum. Genet. </span>2008;<span class="ref-vol">82</span>:1150–7.</span> [<a href="/pmc/articles/PMC2427205/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2427205</span></a>] [<a href="/pubmed/18455129" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18455129</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.morava.2016.713">Morava E, Tiemes V, Thiel C, Seta N, de Lonlay P, de Klerk H, Mulder M, Rubio-Gozalbo E, Visser G, van Hasselt P, Horovitz DD, de Souza CF, Schwartz IV, Green A, Al-Owain M, Uziel G, Sigaudy S, Chabrol B, van Spronsen FJ, Steinert M, Komini E, Wurm D, Bevot A, Ayadi A, Huijben K, Dercksen M, Witters P, Jaeken J, Matthijs G, Lefeber DJ, Wevers RA. ALG6-CDG: a recognizable phenotype with epilepsy, proximal muscle weakness, ataxia and behavioral and limb anomalies. <span><span class="ref-journal">J Inherit Metab Dis. </span>2016;<span class="ref-vol">39</span>:713–23.</span> [<a href="/pubmed/27287710" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27287710</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.morava.2010.3210">Morava E, Wevers RA, Cantagrel V, Hoefsloot LH, Al-Gazali L, Schoots J, van Rooij A, Huijben K, van Ravenswaaij-Arts CM, Jongmans MC, Sykut-Cegielska J, Hoffmann GF, Bluemel P, Adamowicz M, van Reeuwijk J, Ng BG, Bergman JE, van Bokhoven H, K&#x000f6;rner C, Babovic-Vuksanovic D, Willemsen MA, Gleeson JG, Lehle L, de Brouwer AP, Lefeber DJ. A novel cerebello-ocular syndrome with abnormal glycosylation due to abnormalities in dolichol metabolism. <span><span class="ref-journal">Brain. </span>2010;<span class="ref-vol">133</span>:3210–20.</span> [<a href="/pmc/articles/PMC6276930/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6276930</span></a>] [<a href="/pubmed/20852264" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20852264</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.morava.2007.638">Morava E, Zeevaert R, Korsch E, Huijben K, Wopereis S, Matthijs G, Keymolen K, Lefeber DJ, De Meirleir L, Wevers RA. A common mutation in the COG7 gene with a consistent phenotype including microcephaly, adducted thumbs, growth retardation, VSD and episodes of hyperthermia. <span><span class="ref-journal">Eur J Hum Genet. </span>2007;<span class="ref-vol">15</span>:638–45.</span> [<a href="/pubmed/17356545" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17356545</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.ng.2016.653">Ng BG, Shiryaev SA, Rymen D, Eklund EA, et al.  ALG1-CDG: Clinical and Molecular Characterization of 39 Unreported Patients. <span><span class="ref-journal">Hum Mutat. </span>2016;<span class="ref-vol">37</span>:653–60.</span> [<a href="/pmc/articles/PMC4907823/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4907823</span></a>] [<a href="/pubmed/26931382" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26931382</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.ng.2015.1048">Ng BG, Raymond K, Kircher M, Buckingham KJ, et al.  Expanding the molecular and clinical phenotype of SSR4-CDG. <span><span class="ref-journal">Hum Mutat. </span>2015;<span class="ref-vol">36</span>:1048–51.</span> [<a href="/pmc/articles/PMC4604052/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4604052</span></a>] [<a href="/pubmed/26264460" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26264460</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.ng.2011.364">Ng BG, Sharma V, Sun L, Loh E, Hong W, Tay SK, Freeze HH. Identification of the first&#x000a0;COG-CDG&#x000a0;patient of Indian origin. <span><span class="ref-journal">Mol Genet Metab. </span>2011;<span class="ref-vol">102</span>:364–7.</span> [<a href="/pmc/articles/PMC3058693/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3058693</span></a>] [<a href="/pubmed/21185756" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21185756</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.ng.2007.201">Ng BG, Kranz C, Hagebeuk EE, Duran M, Abeling NG, Wuyts B, Ungar D, Lupashin V, Hartdorff CM, Poll-The BT, Freeze HH. Molecular and clinical characterization of a Moroccan Cog7 deficient patient. <span><span class="ref-journal">Mol Genet Metab. </span>2007;<span class="ref-vol">91</span>:201–4.</span> [<a href="/pmc/articles/PMC1941618/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1941618</span></a>] [<a href="/pubmed/17395513" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17395513</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.niehues.1998.1414">Niehues R, Hasilik M, Alton G, Korner C, Schiebe-Sukumar M, Koch HG, Zimmer KP, Wu R, Harms E, Reiter K, von Figura K, Freeze HH, Harms HK, Marquardt T. Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy. <span><span class="ref-journal">J Clin Invest. </span>1998;<span class="ref-vol">101</span>:1414–20.</span> [<a href="/pmc/articles/PMC508719/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC508719</span></a>] [<a href="/pubmed/9525984" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9525984</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.ondruskova.2012.760">Ondruskova N, Vesela K, Hansikova H, Magner M, Zeman J, Honzik T. RFT1-CDG&#x000a0;in adult siblings with novel mutations. <span><span class="ref-journal">Mol Genet Metab. </span>2012;<span class="ref-vol">107</span>:760–2.</span> [<a href="/pubmed/23111317" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23111317</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.paesoldburda.2009.4350">Paesold-Burda P, Maag C, Troxler H, Foulquier F, Kleinert P, Schnabel S, Baumgartner M, Hennet T. Deficiency in COG5 causes a moderate form of congenital disorders of glycosylation. <span><span class="ref-journal">Hum Mol Genet. </span>2009;<span class="ref-vol">18</span>:4350–6.</span> [<a href="/pubmed/19690088" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19690088</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.peters.2002.27">Peters V, Penzien JM, Reiter G, Korner C, Hackler R, Assmann B, Fang J, Schaefer JR, Hoffmann GF, Heidemann PH. Congenital disorder of glycosylation IId (CDG-IId) -- a new entity: clinical presentation with Dandy-Walker malformation and myopathy. <span><span class="ref-journal">Neuropediatrics. </span>2002;<span class="ref-vol">33</span>:27–32.</span> [<a href="/pubmed/11930273" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11930273</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.rafiq.2011.176">Rafiq MA, Kuss AW, Puettmann L, Noor A, Ramiah A, Ali G, Hu H, Kerio NA, Xiang Y, Garshasbi M, Khan MA, Ishak GE, Weksberg R, Ullmann R, Tzschach A, Kahrizi K, Mahmood K, Naeem F, Ayub M, Moremen KW, Vincent JB, Ropers HH, Ansar M, Najmabadi H. Mutations in the alpha 1,2-mannosidase gene, MAN1B1, cause autosomal-recessive intellectual disability. <span><span class="ref-journal">Am J Hum Genet. </span>2011;<span class="ref-vol">89</span>:176–82.</span> [<a href="/pmc/articles/PMC3135808/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3135808</span></a>] [<a href="/pubmed/21763484" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21763484</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.reynders.2009.3244">Reynders E, Foulquier F, Teles EL, Quelhas D, Morelle W, Rabouille C, Annaert W, Matthijs G. Golgi function and dysfunction in the first COG4-deficient CDG type II patient. <span><span class="ref-journal">Hum Molec Genet. </span>2009;<span class="ref-vol">18</span>:3244–56.</span> [<a href="/pmc/articles/PMC2722986/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2722986</span></a>] [<a href="/pubmed/19494034" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19494034</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.rind.2010.1413">Rind N, Schmeiser V, Thiel C, Absmanner B, L&#x000fc;bbehusen J, Hocks J, Apeshiotis N, Wilichowski E, Lehle L, K&#x000f6;rner C. A severe human metabolic disease caused by deficiency of the endoplasmatic mannosyltransferase hALG11 leads to congenital disorder of glycosylation-Ip. <span><span class="ref-journal">Hum Mol Genet. </span>2010;<span class="ref-vol">19</span>:1413–24.</span> [<a href="/pubmed/20080937" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20080937</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.rymen.2014.699">Rymen D, Jaeken J. Skin manifestations in CDG. <span><span class="ref-journal">J Inherit Metab Dis. </span>2014;<span class="ref-vol">37</span>:699–708.</span> [<a href="/pubmed/24554337" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24554337</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.rymen.2012.94">Rymen D, Keldermans L, Race V, R&#x000e9;gal L, Deconinck N, Dionisi-Vici C, Fung CW, Sturiale L, Rosnoblet C, Foulquier F, Matthijs G, Jaeken J. COG5-CDG: expanding the clinical spectrum. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2012;<span class="ref-vol">7</span>:94.</span> [<a href="/pmc/articles/PMC3697985/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3697985</span></a>] [<a href="/pubmed/23228021" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23228021</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.sabry.2016.84">Sabry S, Vuillaumier-Barrot S, Mintet E, Fasseu M, Valayannopoulos V, H&#x000e9;ron D, Dorison N, Mignot C, Seta N, Chantret I, Dupr&#x000e9; T, Moore SE. A case of fatal Type I congenital disorders of glycosylation (CDG&#x000a0;I) associated with low dehydrodolichol diphosphate synthase (DHDDS) activity. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2016;<span class="ref-vol">11</span>:84.</span> [<a href="/pmc/articles/PMC4919849/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4919849</span></a>] [<a href="/pubmed/27343064" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27343064</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.sadat.2014.1615">Sadat MA, Moir S, Chun TW, Lusso P, Kaplan G, et al.  Glycosylation, hypogammaglobulinemia, and resistance to viral infections. <span><span class="ref-journal">N Engl J Med. </span>2014;<span class="ref-vol">370</span>(17):1615–25.</span> [<a href="/pmc/articles/PMC4066413/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4066413</span></a>] [<a href="/pubmed/24716661" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24716661</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.sanznebot.2007.1949">Sanz-Nebot V, Balaguer E, Benavente F, Neusub C, Barbosa J. Characterization of transferrin glycoforms in human serum by CE-UV and CE-ESI-MS. <span><span class="ref-journal">Electrophoresis. </span>2007;<span class="ref-vol">28</span>:1949–57.</span> [<a href="/pubmed/17523137" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17523137</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.schenk.2001.1687">Schenk B, Imbach T, Frank CG, Grubenmann CE, Raymond GV, Hurvitz H, Korn-Lubetzki I, Revel-Vik S, Raas-Rotschild A, Luder AS, Jaeken J, Berger EG, Matthijs G, Hennet T, Aebi M. MPDU1 mutations underlie a novel human congenital disorder of glycosylation, designated type If. <span><span class="ref-journal">J Clin Invest. </span>2001;<span class="ref-vol">108</span>:1687–95.</span> [<a href="/pmc/articles/PMC200989/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC200989</span></a>] [<a href="/pubmed/11733564" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11733564</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.schollen.2004a.550">Schollen E, Frank CG, Keldermans L, Reyntjens R, Grubenmann CE, Clayton PT, Winchester BG, Smeitink J, Wevers RA, Aebi M, Hennet T, Matthijs G. Clinical and molecular features of three patients with congenital disorders of glycosylation type Ih (CDG-Ih) (ALG8 deficiency). <span><span class="ref-journal">J Med Genet. </span>2004a;<span class="ref-vol">41</span>:550–6.</span> [<a href="/pmc/articles/PMC1735831/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735831</span></a>] [<a href="/pubmed/15235028" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15235028</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.schollen.2004b.877">Schollen E, Kjaergaard S, Martinsson T, Vuillaumier-Barrot S, Dunoe M, Keldermans L, Seta N, Matthijs G. Increased recurrence risk in congenital disorders of glycosylation type Ia (CDG-Ia) due to a transmission ratio distortion. <span><span class="ref-journal">J Med Genet. </span>2004b;<span class="ref-vol">41</span>:877–80.</span> [<a href="/pmc/articles/PMC1735620/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735620</span></a>] [<a href="/pubmed/15520415" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15520415</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.schwarz.2004.472">Schwarz M, Thiel C, L&#x000fc;bbehusen J, Dorland B, de Koning T, von Figura K, Lehle L, K&#x000f6;rner C. Deficiency of GDP-Man:GlcNAc2-PP-dolichol mannosyltransferase causes congenital disorder of glycosylation type Ik. <span><span class="ref-journal">Am J Hum Genet. </span>2004;<span class="ref-vol">74</span>:472–81.</span> [<a href="/pmc/articles/PMC1182261/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1182261</span></a>] [<a href="/pubmed/14973778" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14973778</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.serrano.2015.138">Serrano M, de Diego V, Muchart J, Cuadras D, et al.  Phosphomannomutase deficiency (PMM2-CDG): ataxia and cerebellar assessment. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2015;<span class="ref-vol">10</span>:138.</span> [<a href="/pmc/articles/PMC4623922/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4623922</span></a>] [<a href="/pubmed/26502900" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26502900</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.sinha.2009.2591">Sinha MD, Horsfield C, Komaromy D, Booth C, Champion M. Congenital disorders of glycosylation: a rare cause of nephrotic syndrome. <span><span class="ref-journal">Nephrol Dial Transplant. </span>2009;<span class="ref-vol">24</span>:2591–4.</span> [<a href="/pubmed/19474279" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19474279</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.shrimal.2013.4638">Shrimal S, Ng BG, Losfeld ME, Gilmore R, Freeze HH. Mutations in STT3A and STT3B cause two congenital disorders of glycosylation. <span><span class="ref-journal">Hum Mol Genet. </span>2013;<span class="ref-vol">22</span>:4638–45.</span> [<a href="/pmc/articles/PMC3888133/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3888133</span></a>] [<a href="/pubmed/23842455" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23842455</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.spaapen.2005.707">Spaapen LJM, Bakker JA, van der Meer SB, Sijstermans HJ, Steet RA, Wevers RA, Jaeken J. Clinical and biochemical presentation of siblings with COG-7 deficiency, a lethal multiple O- and N-glycosylation disorder. <span><span class="ref-journal">J Inherit Metab Dis. </span>2005;<span class="ref-vol">28</span>:707–14.</span> [<a href="/pubmed/16151902" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16151902</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.stibler.1994.71">Stibler H, Skovby F. Failure to diagnose carbohydrate-deficient glycoprotein syndrome prenatally. <span><span class="ref-journal">Pediatr Neurol. </span>1994;<span class="ref-vol">11</span>:71.</span> [<a href="/pubmed/7527215" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7527215</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.stojkovic.2009.425">Stojkovic T, Vissing J, Petit F, Piraud M, Orngreen MC, Andersen G, Claeys KG, Wary C, Hogrel J-Y, Laforet P. Muscle glycogenosis due to phosphoglucomutase 1 deficiency. <span><span class="ref-journal">New Eng J Med. </span>2009;<span class="ref-vol">361</span>:425–7.</span> (Letter) [<a href="/pubmed/19625727" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19625727</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.st_lting.2009.305">St&#x000f6;lting T, Omran H, Erlekotte A, Denecke J, Reunert J, Marquardt T. Novel ALG8 mutations expand the clinical spectrum of congenital disorder of glycosylation type Ih. <span><span class="ref-journal">Mol Genet Metab. </span>2009;<span class="ref-vol">98</span>:305–9.</span> [<a href="/pubmed/19648040" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19648040</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.sun.2005.22">Sun L, Eklund EA, Van Hove JL, Freeze HH, Thomas JA. Clinical and molecular characterization of the first adult congenital disorder of glycosylation (CDG) type Ic patient. <span><span class="ref-journal">Am J Med Genet A. </span>2005;<span class="ref-vol">137</span>:22–6.</span> [<a href="/pubmed/16007612" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16007612</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.tamminga.2008.762">Tamminga RY, Lefeber DJ, Kamps WA, van Spronsen FJ. Recurrent thrombo-embolism in a child with a congenital disorder of glycosylation (CDG) type Ib and treatment with mannose. <span><span class="ref-journal">Pediatr Hematol Oncol. </span>2008;<span class="ref-vol">25</span>:762–8.</span> [<a href="/pubmed/19065443" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19065443</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.thiel.2002.195">Thiel C, Schwarz M, Hasilik M, Grieben U, Hanefeld F, Lehle L, von Figura K, K&#x000f6;rner C. Deficiency of dolichyl-P-Man:Man7GlcNAc2-PP-dolichyl mannosyltransferase causes congenital disorder of glycosylation type Ig. <span><span class="ref-journal">Biochem J. </span>2002;<span class="ref-vol">367</span>:195–201.</span> [<a href="/pmc/articles/PMC1222867/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1222867</span></a>] [<a href="/pubmed/12093361" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12093361</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.thiel.2003.22498">Thiel C, Schwarz M, Peng J, Grzmil M, Hasilik M, Braulke T, Kohlschutter A, von Figura K, Lehle L, Korner C. A new type of congenital disorders of glycosylation (CDG-Ii) provides new insights into the early steps of dolichol-linked oligosaccharide biosynthesis. <span><span class="ref-journal">J Biol Chem. </span>2003;<span class="ref-vol">278</span>:22498–505.</span> [<a href="/pubmed/12684507" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12684507</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.thiel.2012.485">Thiel C, Rind N, Popovici D, Hoffmann GF, Hanson K, Conway RL, Adamski CR, Butler E, Scanlon R, Lambert M, Apeshiotis N, Thiels C, Matthijs G, Korner C. Improved diagnostics lead to identification of three new patients with congenital disorder of glycosylation-Ip. <span><span class="ref-journal">Hum Mutat. </span>2012;<span class="ref-vol">33</span>:485–7.</span> [<a href="/pubmed/22213132" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22213132</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.timal.2012.4151">Timal S, Hoischen A, Lehle L, Adamowicz M, Huijben K, Sykut-Cegielska J, Paprocka J, Jamroz E, van Spronsen FJ, Korner C, Gilissen C, Rodenburg RJ, Eidhof I, Van den Heuvel L, Thiel C, Wevers RA, Morava E, Veltman J, Lefeber DJ. Gene identification in the congenital disorders of glycosylation type I by whole-exome sequencing. <span><span class="ref-journal">Hum Mol Genet. </span>2012;<span class="ref-vol">21</span>:4151–61.</span> [<a href="/pubmed/22492991" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22492991</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.van_de_kamp.2007.277">van de Kamp JM, Lefeber DJ, Ruijter GJ, Steggerda SJ, den Hollander NS, Willems SM, Matthijs G, Poorthuis BJ, Wevers RA. Congenital disorders of glycosylation type Ia presenting with hydrops fetalis. <span><span class="ref-journal">J Med Genet. </span>2007;<span class="ref-vol">44</span>:277–80.</span> [<a href="/pmc/articles/PMC2598051/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2598051</span></a>] [<a href="/pubmed/17158594" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17158594</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.van_geet.2001.477">Van Geet C, Jaeken J, Freson K, Lenaerts T, Arnout J, Vermylen J, Hoylaerts MF. Congenital disorders of glycosylation type Ia and IIa are associated with different primary haemostatic complications. <span><span class="ref-journal">J Inherit Metab Dis. </span>2001;<span class="ref-vol">24</span>:477–92.</span> [<a href="/pubmed/11596651" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11596651</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.varki.1993.97">Varki A. Biological roles of oligosaccharides: all of the theories are correct. <span><span class="ref-journal">Glycobiology. </span>1993;<span class="ref-vol">3</span>:97–130.</span> [<a href="/pubmed/8490246" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8490246</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.vleugels.2009.1428">Vleugels W, Haeuptle MA, Ng BG, Michalski JC, Battini R, Dionisi-Vici C, Ludman MD, Jaeken J, Foulquier F, Freeze HH, Matthijs G, Hennet T. RFT1 deficiency in three novel CDG patients. <span><span class="ref-journal">Hum Mutat. </span>2009;<span class="ref-vol">30</span>:1428–34.</span> [<a href="/pmc/articles/PMC3869400/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3869400</span></a>] [<a href="/pubmed/19701946" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19701946</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.weinstein.2005.194">Weinstein M, Schollen E, Matthijs G, Neupert C, Hennet T, Grubenmann CE, Frank CG, Aebi M, Clarke JT, Griffiths A, Seargeant L, Poplawski N. CDG-IL: an infant with a novel mutation in the ALG9 gene and additional phenotypic features. <span><span class="ref-journal">Am J Med Genet A. </span>2005;<span class="ref-vol">136</span>:194–7.</span> [<a href="/pubmed/15945070" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15945070</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.willer.2012.575">Willer T, Lee H, Lommel M, Yoshida-Moriguchi T, de Bernabe DB, Venzke D, Cirak S, Schachter H, Vajsar J, Voit T, Muntoni F, Loder AS, Dobyns WB, Winder TL, Strahl S, Mathews KD, Nelson SF, Moore SA, Campbell KP. ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome. <span><span class="ref-journal">Nat Genet. </span>2012;<span class="ref-vol">44</span>:575.</span> [<a href="/pmc/articles/PMC3371168/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3371168</span></a>] [<a href="/pubmed/22522420" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22522420</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.wu.2004.518">Wu X, Steet RA, Bohorov O, Bakker J, Newell J, Krieger M, Spaapen L, Kornfeld S, Freeze HH. Mutation of the COG complex subunit gene COG7 causes a lethal congenital disorder. <span><span class="ref-journal">Nat Med. </span>2004;<span class="ref-vol">10</span>:518–23.</span> [<a href="/pubmed/15107842" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15107842</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.w_rde.2012.634">W&#x000fc;rde AE, Reunert J, Rust S, Hertzberg C, Haverk&#x000e4;mper S, N&#x000fc;rnberg G, N&#x000fc;rnberg P, Lehle L, Rossi R, Marquardt T. Congenital disorder of glycosylation type Ij (CDG-Ij, DPAGT1-CDG): extending the clinical and molecular spectrum of a rare disease. <span><span class="ref-journal">Mol Genet Metab. </span>2012;<span class="ref-vol">105</span>:634–41.</span> [<a href="/pubmed/22304930" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22304930</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.yang.2013.345">Yang AC, Ng BG, Moore SA, Rush J, Waechter CJ, Raymond KM, Willer T, Campbell KP, Freeze HH, Mehta L. Congenital disorder of glycosylation due to DPM1 mutations presenting with a dystroglycanopathy-type congenital muscular dystrophy. <span><span class="ref-journal">Mol Genet Metab. </span>2013;<span class="ref-vol">110</span>:345–51.</span> [<a href="/pmc/articles/PMC3800268/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3800268</span></a>] [<a href="/pubmed/23856421" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23856421</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.zdebska.2003.224">Zdebska E, Bader-Meunier B, Schischmanoff PO, Dupr&#x000e9; T, Seta N, Tchernia G, Ko&#x0015b;cielak J, Delaunay J. Abnormal glycosylation of red cell membrane band 3 in the congenital disorder of glycosylation Ig. <span><span class="ref-journal">Pediatr Res. </span>2003;<span class="ref-vol">54</span>:224–9.</span> [<a href="/pubmed/12736397" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12736397</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cdg.REF.zhang.2014.1400">Zhang Y, Yu X, Ichikawa M, Lyons JJ, Datta S, Lamborn IT, et al.  Autosomal recessive phosphoglucomutase 3 (PGM3) mutations link glycosylation defects to atopy, immune deficiency, autoimmunity, and neurocognitive impairment. <span><span class="ref-journal">J Allergy Clin Immunol. </span>2014;<span class="ref-vol">133</span>:1400–9.</span> [<a href="/pmc/articles/PMC4016982/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4016982</span></a>] [<a href="/pubmed/24589341" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24589341</span></a>]</div></li></ul></div></div><div id="cdg.Chapter_Notes"><h2 id="_cdg_Chapter_Notes_">Chapter Notes</h2><div id="cdg.Author_Notes"><h3>Author Notes</h3><p>Susan Sparks is a board-certified pediatrician, clinical geneticist, and clinical biochemical geneticist. She is currently a medical director at Sanofi Genzyme. After completion of her genetics and biochemical genetics fellowship at the National Institutes of Health, she held faculty positions at Children's National Medical Center in Washington, DC, and Levine Children's Hospital at Carolinas Medical Center in Charlotte, NC. She received her MD and PhD in molecular biology and pharmacology from the Chicago Medical School in 1997 and 1999, respectively.</p><p>Donna Krasnewich is a board-certified clinical biochemical geneticist and pediatrician. She trained at Wayne State University School of Medicine in Detroit, Michigan, and received her MD and PhD in pharmacology in 1986. After completing her fellowship in genetics at the National Institutes of Health (NIH), she joined the faculty of the National Human Genome Research Institutes (NHGRI) at NIH and was the Deputy Clinical Director of NHGRI. She is currently a Program Director at NIH in the National Institute of General Medical Sciences and continues her interest in children with developmental delay and <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> disorders of glycosylation.</p></div><div id="cdg.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>12 January 2017 (ma) Comprehensive update posted live</div></li><li class="half_rhythm"><div>30 January 2014 (cd) Revision: scope of the overview changed to N-linked glycosylation</div></li><li class="half_rhythm"><div>8 November 2012 (cd) Revision: molecular testing for mutations in <i>TMEM165</i> and <i>PGM1</i> available clinically</div></li><li class="half_rhythm"><div>9 August 2012 (cd) Revision: SRD5A3-CDG (CDG-Iq), DDOST-CDG (CDG-Ir), TUSC3-CDG, and <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> disorders of glycosylation multigene panels now listed in the GeneTests&#x02122; Laboratory Directory; CDG types and associated references added</div></li><li class="half_rhythm"><div>11 August 2011 (cd) Revision: clinical testing available for MAGT1-CDG.</div></li><li class="half_rhythm"><div>21 April 2011 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>1 September 2009 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> available clinically for CDG-Io</div></li><li class="half_rhythm"><div>18 December 2008 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> available clinically for CDG-Im, -In, -Ic, -Id, and -If</div></li><li class="half_rhythm"><div>23 June 2008 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>15 August 2005 (me) Overview posted live</div></li><li class="half_rhythm"><div>27 February 2004 (dk) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1332</span><span class="label">PMID: <a href="/pubmed/20301507" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301507</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/cdh-ov/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/cda1/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1332&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1332/?report=reader">PubReader</a></li><li><a href="/books/NBK1332/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1332" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1332" style="display:none" title="Cite this Page"><div class="bk_tt">Sparks SE, Krasnewich DM. Congenital Disorders of N-Linked Glycosylation and Multiple Pathway Overview. 2005 Aug 15 [Updated 2017 Jan 12]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1332/pdf/Bookshelf_NBK1332.pdf">PDF version of this page</a> (522K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#cdg.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#cdg.Clinical_Characteristics_of_Congenit" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics of Congenital Disorders of Glycosylation</a></li><li><a href="#cdg.Causes_of_Congenital_Disorders_of_Gl" ref="log$=inpage&amp;link_id=inpage">Causes of Congenital Disorders of Glycosylation</a></li><li><a href="#cdg.Evaluation_Strategy" ref="log$=inpage&amp;link_id=inpage">Evaluation Strategy</a></li><li><a href="#cdg.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#cdg.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#cdg.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#cdg.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#cdg.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4351[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MPI</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=79087[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">ALG12</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=91949[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">COG7</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=79053[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">ALG8</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=7841[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MOGS</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1798[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">DPAGT1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=2683[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">B4GALT1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=54344[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">DPM3</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=6748[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SSR4</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=55858[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">TMEM165</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=5373[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">PMM2</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=8818[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">DPM2</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=84342[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">COG8</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=79868[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">ALG13</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=22845[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">DOLK</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=10559[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SLC35A1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=56052[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">ALG1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=79796[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">ALG9</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=5236[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">PGM1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=29929[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">ALG6</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=9382[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">COG1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=55343[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SLC35C1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=91869[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">RFT1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=10195[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">ALG3</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4247[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MGAT2</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=7991[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">TUSC3</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1650[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">DDOST</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=25839[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">COG4</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=84061[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MAGT1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=79644[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SRD5A3</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=440138[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">ALG11</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=85365[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">ALG2</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=10466[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">COG5</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1470254" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1470254" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/19862844" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Congenital disorders of glycosylation: an update on defects affecting the biosynthesis of dolichol-linked oligosaccharides.</a><span class="source">[Hum Mutat. 2009]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Congenital disorders of glycosylation: an update on defects affecting the biosynthesis of dolichol-linked oligosaccharides.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Haeuptle MA, Hennet T. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Hum Mutat. 2009 Dec; 30(12):1628-41. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24157261" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">ALG1-CDG: a new case with early fatal outcome.</a><span class="source">[Gene. 2014]</span><div class="brieflinkpop offscreen_noflow">ALG1-CDG: a new case with early fatal outcome.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Rohlfing AK, Rust S, Reunert J, Tirre M, Du Chesne I, Wemhoff S, Meinhardt F, Hartmann H, Das AM, Marquardt T. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Gene. 2014 Jan 25; 534(2):345-51. Epub 2013 Oct 21.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/12667607" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Overexpression of GDP-mannose pyrophosphorylase in Saccharomyces cerevisiae corrects defects in dolichol-linked saccharide formation and protein glycosylation.</a><span class="source">[Biochim Biophys Acta. 2003]</span><div class="brieflinkpop offscreen_noflow">Overexpression of GDP-mannose pyrophosphorylase in Saccharomyces cerevisiae corrects defects in dolichol-linked saccharide formation and protein glycosylation.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Janik A, Sosnowska M, Kruszewska J, Krotkiewski H, Lehle L, Palamarczyk G. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Biochim Biophys Acta. 2003 Apr 7; 1621(1):22-30. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/23856421" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Congenital disorder of glycosylation due to DPM1 mutations presenting with dystroglycanopathy-type congenital muscular dystrophy.</a><span class="source">[Mol Genet Metab. 2013]</span><div class="brieflinkpop offscreen_noflow">Congenital disorder of glycosylation due to DPM1 mutations presenting with dystroglycanopathy-type congenital muscular dystrophy.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Yang AC, Ng BG, Moore SA, Rush J, Waechter CJ, Raymond KM, Willer T, Campbell KP, Freeze HH, Mehta L. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Mol Genet Metab. 2013 Nov; 110(3):345-351. Epub 2013 Jun 28.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/25192513" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Congenital disorders of glycosylation with emphasis on cerebellar involvement.</a><span class="source">[Semin Neurol. 2014]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Congenital disorders of glycosylation with emphasis on cerebellar involvement.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Barone R, Fiumara A, Jaeken J. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Semin Neurol. 2014 Jul; 34(3):357-66. Epub 2014 Sep 5.</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301507" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301507" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e040e0839a66ee2ba682db3">Congenital Disorders of N-Linked Glycosylation and Multiple Pathway Overview - G...</a><div class="ralinkpop offscreen_noflow">Congenital Disorders of N-Linked Glycosylation and Multiple Pathway Overview - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:34:00-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal106&amp;ncbi_phid=CE8DCFAFE04076A10000000002BE00F2&amp;ncbi_session=CE8DCFAFE040E071_0702SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1332%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1332&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1332/&amp;ncbi_pagename=Congenital Disorders of N-Linked Glycosylation and Multiple Pathway Overview - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8DCFAFE040E071_0702SID /projects/books/PBooks@5.22 portal106 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>